Veeda Lifesciences offers a comprehensive suite of bioanalytical assays for Generics, New Chemical Entities (NCEs), Biotherapeutics. Our services include custom assay development, validation and sample analysis for small molecules and large molecules, with focus on pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity testing and biomarker analysis. Leveraging advanced ligand-binding platforms and mass spectrometry technologies, we ensure high-quality and precise results. Our assays support all stages of drug development, including biosimilar development, ensuring regulatory compliance and the highest scientific standards.
Drug Name | Therapeutic Class | Category | Platform | Concentration Range | Status | |
---|---|---|---|---|---|---|
LLOQ | ULOQ | |||||
21-Desacetyl Deflazacort | Corticosteroids | Generic | LC/MS/MS | 0.5 | 400 | Validated |
4-Methyl amino antipyrine | Antipyrine | Generic | LC/MS/MS | 300 | 90000 | Validated |
2-pyridylacetic acid | Pyridines and derivatives | Generic | LC/MS/MS | 5 | 2500 | Validated |
Abacavir | Antiviral | Generic | LC/MS/MS | 30 | 7500 | Validated |
Abacavir | Antiviral | Generic | LC/MS/MS | 30 | 9000 | Validated |
Abacavir + Lamivudine | Antiviral | Generic | LC/MS/MS | 24 60 |
6000 15000 |
Validated |
Abiraterone | Metastatic prostate cancer | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Abiraterone | Metastatic prostate cancer | Generic | LC/MS/MS | 5 | 2000 | Validated |
Abiraterone | Metastatic prostate cancer | Generic | LC/MS/MS | 0.4 | 500 | Validated |
Abiraterone & Niraparib | Metastatic prostate cancer | Generic | LC/MS/MS | 1 10 |
300 3000 |
Validated |
Acetaminophen (Paracetamol) | Antipyretic, Analgesic | Generic | LC/MS/MS | 300 | 20000 | Validated |
Acetaminophen (Paracetamol) | Antipyretic, Analgesic | Generic | LC/MS/MS | 200 | 20000 | Validated |
Acetazolamide | Carbonic anhydrase inhibitor, diuretic | Generic | LC/MS/MS | 20 | 20000 | Validated |
Acetazolamide | Carbonic anhydrase inhibitor, diuretic | Generic | LC/MS/MS | 10 | 5000 | Validated |
Acetazolamide | Carbonic anhydrase inhibitor, diuretic | Generic | LC/MS/MS | 30 | 18000 | Validated |
Acetazolamide | Carbonic anhydrase inhibitor, diuretic | Generic | LC/MS/MS | 60 | 30000 | Validated |
Acitretin | Psoriasis | Generic | LC/MS/MS | 0.2 | 300 | Validated |
Acitretin+ 13 - Cis Acitretin | Psoriasis | Generic | LC/MS/MS | 5 | 500 | Validated |
Acitretin and Metabolite | Psoriasis | Generic | LC/MS/MS | 1 0.070 |
300 21 |
Validated |
Acyclovir | Antiviral | Generic | LC/MS/MS | 5 | 2500 | Validated |
Afatinib | Anticancer | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Agomelatine | Antidepressant | Generic | LC/MS/MS | 0.005 | 10 | Validated |
Agomelatine | Antidepressant | Generic | LC/MS/MS | 0.005 | 50 | Validated |
Alfuzosin | Benign prostatic hyperplasia | Generic | LC/MS/MS | 0.05 | 30 | Validated |
Alfuzosin | Antihypertensive | Generic | LC/MS/MS | 0.4 | 80 | Validated |
Alimemazine | Antihistamine | Generic | LC/MS/MS | 0.02 | 10 | Validated |
Aliskiren | Renin inhibitor | Generic | LC/MS/MS | 0.3 | 300 | Validated |
All Trans Acitretin & 13-Cis Acitretin | Psoriasis | Generic | LC/MS/MS | 1 0.200 |
400 80 |
Validated |
Alogliptin | Antidiabetic | Generic | LC/MS/MS | 0.8 | 400 | Validated |
Alosetron | 5-HT3 Antagonist | Generic | LC/MS/MS | 0.05 | 20 | Validated |
Alprazolam | Anxiolytic | Generic | LC/MS/MS | 0.2 | 40 | Validated |
Allopurinol | Anti gout | Generic | LC/MS/MS | 15 | 9000 | Validated |
Alverine + 4-Hydroxy Alverine | Smooth muscle relaxant | Generic | LC/MS/MS | 0.01 0.05 |
3 15 |
Validated |
Aminocaproic acid | Bleeding Disorders | Generic | LC/MS/MS | 500 | 100000 | Validated |
Amisulpride | Antipsychotic | Generic | LC/MS/MS | 5 | 2500 | Validated |
Amlodipine + Valsartan | Antihypertensive | Generic | LC/MS/MS | 0.10 100 |
10 10000 |
Validated |
Amlodipine + Valsartan | Antihypertensive | Generic | LC/MS/MS | 0.10 40 |
12 4800 |
Validated |
Amoxicillin | Antibacterial | Generic | LC/MS/MS | 80 | 40000 | Validated |
Albendazole + Albendazole Sulfoxide | Anthelmintic | Generic | LC/MS/MS | 0.20 4 |
100 2000 |
Validated |
Amantadine | Antiviral and an Antiparkinsonian drug | Generic | LC/MS/MS | 2 | 1000 | Validated |
Ambroxol+ Gauifenesin | Expectorant | Generic | LC/MS/MS | 0.40 5 |
200 2500 |
Validated |
Amifampridine | Potassium channel blocker | Generic | LC/MS/MS | 0.14 | 70 | Validated |
Amifampridine | Potassium channel blocker | Generic | LC/MS/MS | 0.14 | 112 | Validated |
Amiodarone | Antiarrhythmic | Generic | LC/MS/MS | 2 | 1000 | Validated |
Amitriptyline+ Nortriptyline | Antidepressant | Generic | LC/MS/MS | 0.20 0.08 |
120 48 |
Validated |
Amitriptyline+ Nortriptyline | Antidepressant | Generic | LC/MS/MS | 0.20 0.09 |
120 48.1 |
Validated |
Amitriptyline+ Nortriptyline | Antidepressant | Generic | LC/MS/MS | 0.20 0.050 |
80 20 |
Validated |
Amlodipine | Antihypertensive | Generic | LC/MS/MS | 0.03 | 10 | Validated |
Amlodipine+ Celecoxib | Antihypertensive / NSAID | Generic | LC/MS/MS | 0.10 10 |
25 2500 |
Validated |
Amlodipine+ HCTZ+ Olmesartan | Antihypertensive | Generic | LC/MS/MS | 0.05 1 10 |
15 300 3000 |
Validated |
Amlodipine + Olmesartan | Antihypertensive | Generic | LC/MS/MS | 0.040 10 |
12 3000 |
Validated |
Amlodipine + Telmisartan | Antihypertensive | Generic | LC/MS/MS | 0.05 5 |
10 1000 |
Validated |
Amlodipine+ Valsartan | Antihypertensive | Generic | LC/MS/MS | 0.10 40 |
12 4800 |
Validated |
S-Amlodipine | Antihypertensive | Generic | LC/MS/MS | 0.03 | 12 | Validated |
S-Amlodipine + Hydrochlorothiazide | Antihypertensive | Generic | LC/MS/MS | 0.03 1 |
12 400 |
Validated |
S-Amlodipine + Hydrochlorothiazide | Antihypertensive | Generic | LC/MS/MS | 0.03 1. |
12 400 |
Validated |
Amoxicillin | Antibacterial | Generic | LC/MS/MS | 160 | 30000 | Validated |
Amoxicillin | Antibacterial | Generic | LC/MS/MS | 200 | 30000 | Validated |
Amoxicillin | Antibacterial | Generic | LC/MS/MS | 50 | 25000 | Validated |
Amoxicillin and Clavulanic Acid | Antibacterial | Generic | LC/MS/MS | 150 15 |
30000 3000 |
Validated |
Anastrozole | Anticancer | Generic | LC/MS/MS | 0.2 | 60 | Validated |
Apalutamide | Anti-Androgens | Generic | LC/MS/MS | 50 | 20000 | Validated |
Apalutamide | Anti-Androgens | Generic | LC/MS/MS | 10 | 12000 | Validated |
Apalutamide | Androgen receptor inhibitors | Generic | LC/MS/MS | 10 | 1600 | Validated |
Apixaban | Oral Anticoagulant | Generic | LC/MS/MS | 1 | 400 | Validated |
Apremilast | Psoriatic Arthritis | Generic | LC/MS/MS | 4 | 800 | Validated |
Aprepitant | Antiemetic | Generic | LC/MS/MS | 20 | 4000 | Validated |
Aprepitant | Antiemetic | Generic | LC/MS/MS | 20 | 8000 | Validated |
Aprepitant | Antiemetics | Generic | LC/MS/MS | 30 | 12000 | Validated |
Aprepitant | Antiemetic | Generic | LC/MS/MS | 50 | 35000 | Validated |
Aripriprazole | Antipsychotic | Generic | LC/MS/MS | 0.5 | 400 | Validated |
Aripiprazole | Antipsychotic | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Aripiprazole | Antipsychotic | Generic | LC/MS/MS | 2 | 800 | Validated |
Aripriprazole+ Escitalopram | Antipsychotic, Antidepressant | Generic | LC/MS/MS | 0.25 0.10 |
65 24 |
Validated |
Armodafinil | Wakefulness promoting agent | Generic | LC/MS/MS | 50 | 15000 | Validated |
Artemether +Dihydroartimisnin | Antimalarial | Generic | LC/MS/MS | 3 | 360 | Validated |
Artimether+ Dihydroartemisinin | Antimalarial | Generic | LC/MS/MS | 0.50 0.50 |
300 300 |
Validated |
Artesunate + Dihydroartemisinin | Antimalarial | Generic | LC/MS/MS | 0.800 0.800 |
500 500 |
Validated |
Asenapine | Antipsychotic | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Asenapine | Antipsychotic | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Aspirin+ Salicylic Acid | Analgesic | Generic | LC/MS/MS | 2000 | 80000 | Validated |
Aspirin+ Salicylic acid | Analgesic | Generic | LC/MS/MS | 4 100 |
2000 7000 |
Validated |
Aspirin(Sensitive) | Analgesic | Generic | LC/MS/MS | 10 | 2000 | Validated |
Atazanavir | Antiviral | Generic | LC/MS/MS | 30 | 15000 | Validated |
Atazanavir | Antiviral | Generic | LC/MS/MS | 20 | 8000 | Validated |
Atenolol | Antihypertensive | Generic | LC/MS/MS | 8 | 2200 | Validated |
Atenolol | Antihypertensive | Generic | LC/MS/MS | 10 | 1500 | Validated |
Atomoxetine | Hyperactivity disorder (ADHD) | Generic | LC/MS/MS | 5 | 2000 | Validated |
Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.2 | 200 | Validated |
Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.5 | 300 | Validated |
Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.25 | 400 | Validated |
Atorvastatin+ 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.25 0.50 0.50 |
50 100 100 |
Validated |
Atorvastatin + 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.10 0.10 0.05 |
100 100 50 |
Validated |
Atorvastatin+ 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.2 0.2 0.1 |
200 200 100 |
Validated |
Atorvastatin + 2- Hydroxy Atorvastatin + 4- Hydroxy Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.020 0.020 0.010 |
20 20 10 |
Validated |
Atorvastatin + 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin+ Glimpride | Antihyperlipidemic Antidiabetic |
Generic | LC/MS/MS | 0.1 0.1 0.05 0.50 |
40 40 20 200 |
Validated |
Atorvastatin + 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.32 0.224 0.048 |
200 140 30 |
Validated |
Atovaquone | Antiprotozoal | Generic | LC/MS/MS | 100 | 20000 | Validated |
Avatrombopag | Thrombopoietin receptor agonists | Generic | LC/MS/MS | 0.5 | 300 | Validated |
Axitinib | Anticancer | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Axitinib | Anticancer | Generic | LC/MS/MS | 0.075 | 100 | Validated |
Axitinib | Anticancer | Generic | LC/MS/MS | 0.25 | 150 | Validated |
Azacitidine | Anticancer | Generic | LC/MS/MS | 1 | 700 | Validated |
Azilsartan | Antihypertensive | Generic | LC/MS/MS | 30 | 15000 | Validated |
Azilsartan + Chlorthalidone | Antihypertensive | Generic | LC/MS/MS | 10 2 |
5000 1000 |
Validated |
Azithromycin | Antibiotics | Generic | LC/MS/MS | 5 | 1000 | Validated |
Azithromycin | Antibiotic | Generic | LC/MS/MS | 5 | 2000 | Validated |
Azythromycin | Antibiotic | Generic | LC/MS/MS | 1 | 400 | Validated |
Azithromycin | Antibiotics | Generic | LC/MS/MS | 1 | 700 | Validated |
Baclofen | Muscle relaxant and antispastic | Generic | LC/MS/MS | 5 | 1000 | Validated |
Baclofen | Muscle relaxant and antispastic | Generic | LC/MS/MS | 3 | 2400 | Validated |
Baloxavir | Antiviral | Generic | LC/MS/MS | 0.5 | 500 | Validated |
Barnidipine | Antihypertensive | Generic | LC/MS/MS | 0.02 | 10 | Validated |
Barnidipine | Antihypertensive | Generic | LC/MS/MS | 0.004 | 8 | Validated |
Belumosudil | Serine/threonine kinase inhibitors | Generic | LC/MS/MS | 50 | 35000 | Validated |
Bempedoic Acid | ACL inhibitors | Generic | LC/MS/MS | 200 | 24000 | Validated |
Bempedoic Acid and its Metabolite ESP-15228 | ACL inhibitors | Generic | LC/MS/MS | 75 7.500 |
30000 3000 |
Validated |
Benazepril + Benazeprilat | Antihypertensive | Generic | LC/MS/MS | 1 2 |
400 800 |
Validated |
Bendroflumethiazide | Antihypertensive | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Benzonatate + 4-Butylamino Benzoic Acid | Symptomatic relief of cough. | Generic | LC/MS/MS | 0.050 3 |
100 6000 |
Validated |
Bexarotene | Anticancer | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Bilastine | Antihistamine | Generic | LC/MS/MS | 2 | 600 | Validated |
Binimetinib | Anti-cancer | Generic | LC/MS/MS | 1 | 500 | Validated |
Bisoprolol | Antihypertensive | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Bisoprolol | Antihypertensive | Generic | LC/MS/MS | 0.2 | 150 | Validated |
Bisoprolol + Hydrochlorothiazide | Antihypertensive | Generic | LC/MS/MS | 0.50 0.50 |
100 100 |
Validated |
Bortezomib | Anticancer | Generic | LC/MS/MS | 2 | 1400 | Validated |
Bortezomib | Anticancer | Generic | LC/MS/MS | 0.225 | 50 | Validated |
Bortezomib | Anticancer | Generic | LC/MS/MS | 0.225 | 50 | Validated |
Bosentan | Antihypertensive | Generic | LC/MS/MS | 50 | 5000 | Validated |
Bosentan(Sensitive) | Endothelin receptor antagonist | Generic | LC/MS/MS | 20 | 5000 | Validated |
Bosentan | Antihypertensive | Generic | LC/MS/MS | 10 | 5000 | Validated |
Bosutinib | Anticancer | Generic | LC/MS/MS | 0.2 | 120 | Validated |
Bosutinib | Anti cancer | Generic | LC/MS/MS | 1 | 600 | Validated |
Brexpiprazole | Antipsychotic | Generic | LC/MS/MS | 0.2 | 60 | Validated |
Brexpiprazole | Antipsychotic | Generic | LC/MS/MS | 0.2 | 150 | Validated |
Briquinor + Dipyridamole | Vasodilator | Generic | LC/MS/MS | 5 | 2000 | Validated |
Brivaracetam | Anticonvulsants | Generic | LC/MS/MS | 20 | 8000 | Validated |
Budesonide | Glucocorticoid | Generic | LC/MS/MS | 0.01 | 4.5 | Validated |
Budesonide | Glucocorticoid | Generic | LC/MS/MS | 0.015 | 4.5 | Validated |
Budesonide | Glucocorticoid | Generic | LC/MS/MS | 0.01 | 8 | Validated |
Bumetanide | Diuretic | Generic | LC/MS/MS | 1 | 200 | Validated |
Bupivacaine | Antihistamine | Generic | LC/MS/MS | 5 | 2500 | Validated |
Bupivacaine | Local Anesthetic | Generic | LC/MS/MS | 1 | 500 | Validated |
Bupropion + Hydroxy Bupropion | Antidepressant | Generic | LC/MS/MS | 1.5 | 300 | Validated |
Buspiron | Anxiolytic | Generic | LC/MS/MS | 0.05 | 5 | Validated |
Butylscopolamine (Butylhyoscine) | Abdominal pain | Generic | LC/MS/MS | 0.002 | 0.25 | Validated |
Butylscopolamine (Butylhyoscine) | Abdominal pain | Generic | LC/MS/MS | 0.002 | 800 | Validated |
Cabergoline | Dopamine receptor agonist | Generic | LC/MS/MS | 0.0015 | 0.1 | Validated |
Cabergoline | Dopamine receptor agonist | Generic | LC/MS/MS | 0.0015 | 0.1 | Validated |
Cabozanitinib | Anticancer | Generic | LC/MS/MS | 2 | 1000 | Validated |
Canagliflozin | Antidiabetic | Generic | LC/MS/MS | 10 | 6000 | Validated |
Canagliflozin + Metformin | Antidiabetic | Generic | LC/MS/MS | 5 5 |
3000 3000 |
Validated |
Candesartan | Antihypertensive | Generic | LC/MS/MS | 1 | 500 | Validated |
Candesartan | Antihypertensive | Generic | LC/MS/MS | 2 | 700 | Validated |
Candesartan + Hydrochlorothiazide | Antihypertensive Diuretic |
Generic | LC/MS/MS | 2 1 |
1000 500 |
Validated |
Capecitabine | Anticancer | Generic | LC/MS/MS | 10 | 10000 | Validated |
Capecitabine | Anticancer | Generic | LC/MS/MS | 30 | 27000 | Validated |
Captopril | Antihypertensive | Generic | LC/MS/MS | 5 | 1000 | Validated |
Carbamazepine | Antiepileptic | Generic | LC/MS/MS | 20 | 5000 | Validated |
Carbamazepine | Anticonvulsant | Generic | LC/MS/MS | 20 | 10000 | Validated |
Carbamazepine | Antiepileptic | Generic | LC/MS/MS | 10 | 3000 | Validated |
Carbidopa+ Levodopa | Parkinson's disease | Generic | LC/MS/MS | 2 20 |
400 4000 |
Validated |
Carbidopa + Levodopa | Parkinson's disease | Generic | LC/MS/MS | 0.500 20 |
250 4000 |
Validated |
Carvedilo + 4-Hydroxyphenyl Carvedilol | Beta-blocker | Generic | LC/MS/MS | 0.5 0.150 |
100 30 |
Validated |
Carglumic Acid | Carbamoyl Phosphate Synthetase 1 activator | Generic | LC/MS/MS | 50 | 10000 | Validated |
Carglumic Acid | Carbamoyl Phosphate Synthetase 1 activator | Generic | LC/MS/MS | 10 | 1000 | Validated |
Carglumic Acid | Carbamoyl Phosphate Synthetase 1 activator | Generic | LC/MS/MS | 5 | 1000 | Validated |
Cefaclor | Antibacterial | Generic | LC/MS/MS | 500 | 50000 | Validated |
Cefaclor | Antibiotic | Generic | LC/MS/MS | 200 | 20000 | Validated |
Cefadroxil | Antibiotic | Generic | LC/MS/MS | 300 | 60000 | Validated |
Cefadroxil | Antibiotic | Generic | LC/MS/MS | 200 | 40000 | Validated |
Cefadroxil | Antibiotics | Generic | LC/MS/MS | 200 | 40000 | Validated |
Cefditoren | Antibiotic | Generic | LC/MS/MS | 25 | 5000 | Validated |
Cefixime | Antibacterial | Generic | LC/MS/MS | 100 | 20000 | Validated |
Cefixime | Cephalosporin Antibiotic | Generic | LC/MS/MS | 25 | 15000 | Validated |
Cefixime | Antibacterial | Generic | LC/MS/MS | 100 | 20000 | Validated |
Cefpodoxime acid | Antibacterial | Generic | LC/MS/MS | 20 | 3000 | Validated |
Cefpodoxime acid | Antibacterial | Generic | LC/MS/MS | 200 | 10000 | Validated |
Cefuroxime acid | Antibacterial | Generic | LC/MS/MS | 150 | 30000 | Validated |
Cefuroxime acid | Antibacterial | Generic | LC/MS/MS | 75 | 1500 | Validated |
Cefuroxime | Antibacterial | Generic | LC/MS/MS | 60 | 12000 | Validated |
Celecoxib | NSAID | Generic | LC/MS/MS | 20 | 5000 | Validated |
Celecoxib | NSAID | Generic | LC/MS/MS | 5 | 2500 | Validated |
Cephalexin | Antibacterial | Generic | LC/MS/MS | 200 | 120000 | Validated |
Cephalexin | Antibacterial | Generic | LC/MS/MS | 500 | 50000 | Validated |
Cephalexin | Antibacterial | Generic | LC/MS/MS | 50 | 25000 | Validated |
Cetirizine | Non-sedative Antihistamine | Generic | LC/MS/MS | 5 | 1000 | Validated |
Chlorogenic acid | Antioxidant | Generic | LC/MS/MS | 1 | 2000 | Validated |
Chlorpheniramine + Phenylephrine | Antihistamine Decongestant | Generic | LC/MS/MS | 0.10 0.05 |
20 10 |
Validated |
Chlorpromazine + 7-Hydroxy Chlorpromazine | Antipsychotic | Generic | LC/MS/MS | 0.50 0.20 |
250 100 |
Validated |
Chlorpromazine + 7-Hydroxy Chlorpromazine | Antipsychotic | Generic | LC/MS/MS | 0.020 0.020 |
20 20 |
Validated |
Chlorthalidone | Diruretic | Generic | LC/MS/MS | 20 | 8000 | Validated |
Chlorthalidone | Diruretic | Generic | LC/MS/MS | 2 | 1000 | Validated |
Chlorthalidone +Telmisartan | Antihypertensive | Generic | LC/MS/MS | 1 2 |
250 500 |
Validated |
Chlorzoxazone | Muscle relaxant | Generic | LC/MS/MS | 50 | 20000 | Validated |
Chlorzoxazone | Muscle relaxant | Generic | LC/MS/MS | 200 | 80000 | Validated |
Cinacalcet | Calcimimetics | Generic | LC/MS/MS | 0.4 | 200 | Validated |
Cinnargine | Antihistamine | Generic | LC/MS/MS | 5 | 750 | Validated |
Ciprofloxacin | Antibacterial | Generic | LC/MS/MS | 100 | 10000 | Validated |
Ciprofloxacin | Antibacterial | Generic | LC/MS/MS | 35 | 7000 | Validated |
Citric Acid | Urinary alkalinizers | Generic | LC/MS/MS | 5 | 1000 | Validated |
Clarithromycin | Antibacterial | Generic | LC/MS/MS | 50 | 10000 | Validated |
Clarithromycin + 14(R)-hydroxy-Clarithromycin | Antibacterial | Generic | LC/MS/MS | 40 15 |
8000 3000 |
Validated |
Clarithromycin | Antibacterial | Generic | LC/MS/MS | 10 | 5000 | Validated |
Clavulanic Acid | Beta-lactamase inhibitors | Generic | LC/MS/MS | 36.225 | 10350 | Validated |
Clindamycin | Antibacterial | Generic | LC/MS/MS | 10 | 8000 | Validated |
Clobazam+ N-Desmethyl Clobazam | Antiepileptic | Generic | LC/MS/MS | 5 1 |
1500 300 |
Validated |
Clomipramine+ Desmethyl Clomipramine | Antidepressant | Generic | LC/MS/MS | 1 1 |
300 300 |
Validated |
Clomipramine + Desmethyl Clomipramine | Antidepressant | Generic | LC/MS/MS | 0.20 0.80 |
50 200 |
Validated |
Clomipramine+ Desmethylclomipramine | Antidepressant | Generic | LC/MS/MS | 0.10 0.050 |
6 30 |
Validated |
Clonazepam | Antiepileptic | Generic | LC/MS/MS | 0.2 | 30 | Validated |
Clonazepam | Antiepileptic | Generic | LC/MS/MS | 0.05 | 20 | Validated |
Clonidine | Antihypertensive | Generic | LC/MS/MS | 0.025 | 2.5 | Validated |
Clonidine | Antihypertensive | Generic | LC/MS/MS | 0.003 | 1.5 | Validated |
Clopidogrel | Anti-platelet | Generic | LC/MS/MS | 0.2 | 25 | Validated |
Clopidogrel | Anti-platelet | Generic | LC/MS/MS | 0.05 | 10 | Validated |
Clopidogrel | Anti-platelet | Generic | LC/MS/MS | 0.005 | 5 | Validated |
Clopidogrel | Anti-platelet | Generic | LC/MS/MS | 0.01 | 10 | Validated |
Clopidogrel+ Clopidogrel Carboxylic acid |
Anti-platelet | Generic | LC/MS/MS | 0.05 50 |
10 10000 |
Validated |
Clopidogrel Carboxylic acid | Anti-platelet | Generic | LC/MS/MS | 50 | 10000 | Validated |
Clozapine | Antipsychotic | Generic | LC/MS/MS | 10 | 1000 | Validated |
Cyclobenzaprine | Muscle spasm | Generic | LC/MS/MS | 0.05 | 20 | Validated |
Cyclobenzaprine | Muscle relaxant | Generic | LC/MS/MS | 0.05 | 30 | Validated |
Cyclosporin (Ciclosporin) | Immunosuppressant | Generic | LC/MS/MS | 5 | 2000 | Validated |
Dabigatran (free) | Thrombin Inhibitor | Generic | LC/MS/MS | 1 | 300 | Validated |
Dalfampridine | Multiple sclerosis | Generic | LC/MS/MS | 0.4 | 100 | Validated |
Dapagliflozine | Antidiabetic | Generic | LC/MS/MS | 1 | 500 | Validated |
Dapsone | Antimicrobials | Generic | LC/MS/MS | 25 | 5000 | Validated |
Dapsone+ N-Acetyl Dapsone | Antileprotic | Generic | LC/MS/MS | 0.045 0.015 |
18 6 |
Validated |
Dapsone and its Metabolite | Antileprotic | Generic | LC/MS/MS | 25 25 |
5000 5000 |
Validated |
S-Dapoxetine | Selective serotonin reuptake inhibitor | Generic | LC/MS/MS | 1 | 1000 | Validated |
Dapoxetine+ Tadalafil | Erectile dysfunction | Generic | LC/MS/MS | 2 2 |
800 800 |
Validated |
Darifenacin | Urinary incontinence | Generic | LC/MS/MS | 0.025 | 5 | Validated |
Darifenacin | Urinary incontinence | Generic | LC/MS/MS | 0.025 | 12 | Validated |
Darunavir | Antiretroviral | Generic | LC/MS/MS | 50 | 20000 | Validated |
Darunavir | Antiretroviral | Generic | LC/MS/MS | 50 | 20000 | Validated |
Dasatinib | Anticancer | Generic | LC/MS/MS | 1 | 400 | Validated |
Dasatinib | Anticancer | Generic | LC/MS/MS | 1 | 400 | Validated |
Deferasirox | Iron Chelator | Generic | LC/MS/MS | 100 | 60000 | Validated |
Deferasirox | Iron Chelator | Generic | LC/MS/MS | 100 | 60000 | Validated |
Deferiprone+ Deferiprone Glucuronide | Iron Chelator | Generic | LC/MS/MS | 250 125 |
40000 20000 |
Validated |
Deferiprone | Iron chelators | Generic | LC/MS/MS | 250 | 40000 | Validated |
Desipramine | Antidepressant | Generic | LC/MS/MS | 0.5 | 150 | Validated |
Desipramine +2-Hydroxy Desipramine | Antidepressant | Generic | LC/MS/MS | 0.5 0.15 |
150 45 |
Validated |
Desloratadine | Antihistamine | Generic | LC/MS/MS | 0.2 | 10 | Validated |
Desloratadine + 3-Hydroxy Desloratidine | Antihistamine | Generic | LC/MS/MS | 0.05 | 10 | Validated |
Desloratidine + 3-Hydroxy Desloratidine | Antihistamine | Generic | LC/MS/MS | 0.05 | 10 | Validated |
Desloratidine +3-Hydroxy desloratidine | Antihistamine | Generic | LC/MS/MS | 0.025 0.025 |
7.50 7.50 |
Validated |
Desmopressin | Synthetic replacement of vasopressin harmone | Generic | LC/MS/MS | 1pg/mL | 250pg/mL | Validated |
Desmopressin | Synthetic replacement of vasopressin harmone | Generic | LC/MS/MS | 0.002 | 0.25 | Validated |
Desvenlafaxine | Antidepressant | Generic | LC/MS/MS | 2 | 700 | Validated |
Dexamethasone | Corticosteroid | Generic | LC/MS/MS | 2 | 600 | Validated |
Dexamethasone | Corticosteroid | Generic | LC/MS/MS | 0.25 | 100 | Validated |
Dexamethasone | Corticosteroid | Generic | LC/MS/MS | 0.5 | 150 | Validated |
Dexlansoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 5 | 2500 | Validated |
Dexlansoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 5 | 4000 | Validated |
Dexmedetomidine | Sedatives | Generic | LC/MS/MS | 0.005 | 5 | Validated |
Dextromethorphan+ Dextrorphan | Cough Suppressant | Generic | LC/MS/MS | 0.10 10 |
20 2000 |
Validated |
Dextromethorphan +Dextrorphan | Cough Suppressant | Generic | LC/MS/MS | 0.030 0.030 |
15 15 |
Validated |
Dextromethorphan + Guanafenesin | Cough Suppressant Expectorant | Generic | LC/MS/MS | 0.10 25 |
20 5000 |
Validated |
Diacerein + Rhein | Osteoarthritis | Generic | LC/MS/MS | 15 15 |
6000 6000 |
Validated |
Diazepam | Benzodiazepines | Generic | LC/MS/MS | 1 | 800 | Validated |
Diazoxide | Hyperinsulinism | Generic | LC/MS/MS | 30 | 12000 | Validated |
Diclofenac | Analgesic | Generic | LC/MS/MS | 25 | 4000 | Validated |
Diclofenac | Analgesic | Generic | LC/MS/MS | 10 | 4000 | Validated |
Diclofenac | Analgesic | Generic | LC/MS/MS | 50 | 15000 | Validated |
Dilclofenac | Analgesic | Generic | LC/MS/MS | 2 | 4000 | Validated |
Diclofenac | Analgesic | Generic | LC/MS/MS | 40 | 40000 | Validated |
Diclofenac | Analgesic | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Diclofenac + Esomeprazole | Analgesic Proton pump inhibitor | Generic | LC/MS/MS | 8 4 |
4000 2000 |
Validated |
Dicloxacillin | Antibacterial | Generic | LC/MS/MS | 200 | 80000 | Validated |
Dicyclomine (Dicycloverine) | Antispasmodic | Generic | LC/MS/MS | 0.5 | 120 | Validated |
Dihydroartemisinin | Anitmalerial | Generic | LC/MS/MS | 2 | 1000 | Validated |
Dihydrotetrabenazine | Huntington's disease | Generic | LC/MS/MS | 1 | 200 | Validated |
Diltiazem + N-Desmethyl Diltiazem + Desacetyl Diltiazem | Antihypertensive | Generic | LC/MS/MS | 1.5 0.5 0.5 |
450 150 150 |
Validated |
Diltiazem + N-Desmethyl diltiazem + Desacetyl diltazem | Antihypertensive | Generic | LC/MS/MS | 4 1 0.50 |
1200 300 150 |
Validated |
Diltiazem | Antihypertensive | Generic | LC/MS/MS | 1 | 200 | Validated |
Diphendydramine + Naproxen | Antihistamine NSAID | Generic | LC/MS/MS | 0.50 500 |
150 150000 |
Validated |
Dipyridamole | Vasodilator | Generic | LC/MS/MS | 5 | 4500 | Validated |
Dipyridamole | Vasodilator | Generic | LC/MS/MS | 5 | 5000 | Validated |
Disulfiram Metabolite 2 | For Chronic Alcoholism (Disulfiram) | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Disulfiram Primary Metabolite | Carbamate derivative | Generic | LC/MS/MS | 2 | 200 | Validated |
Docetaxel(Total) | Anticancer | Generic | LC/MS/MS | 10 | 6000 | Validated |
Dofetilide | Antiarrhythmic | Generic | LC/MS/MS | 0.01 | 5 | Validated |
Dolutegravir | Antiviral | Generic | LC/MS/MS | 20 | 8000 | Validated |
Doltegravir + Emtricitabine+ Tenofovir Alafenamide | Antiviral | Generic | LC/MS/MS | 30 20 2 |
7500 5000 500 |
Validated |
Dolutegravir & Repaglinide | Antiviral & antihyperglycemic | Generic | LC/MS/MS | 20 0.05 |
4000 10 |
Validated |
Domperidone | Propulsives | Generic | LC/MS/MS | 0.1 | 40 | Validated |
Donepezil | Alzheimer | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Donepezil | Alzheimer | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Donepezil + Memantine | Alzheimer | Generic | LC/MS/MS | 0.50 0.50 |
200 200 |
Validated |
Donepezil + Memantine |
Alzheimer | Generic | LC/MS/MS | 0.20 0.30 |
60 90 |
Validated |
Dosulepin | Antidepressant | Generic | LC/MS/MS | 0.2 | 120 | Validated |
Doxazosin | Antihypertensive | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Doxepin + Nordoxepin | Antidepressant | Generic | LC/MS/MS | 0.20 0.050 |
80 20 |
Validated |
Doxepin + Nordoxepin | Antidepressant | Generic | LC/MS/MS | 0.005 0.005 |
10 10 |
Validated |
Doxepin + Nordoxepin | Alzheimer | Generic | LC/MS/MS | 0.20 0.050 |
160 40 |
Validated |
Doxorubicin (Total) | Anticancer | Generic | LC/MS/MS | 150 | 60000 | Validated |
Doxylamine & Pyridoxine | Antihistamines & Vitamin B6 | Generic | LC/MS/MS | 0.500 0.500 |
200 200 |
Validated |
Doxycycline | Antibacterial | Generic | LC/MS/MS | 10 | 5000 | Validated |
Doxycycline | Antibacterial | Generic | LC/MS/MS | 10 | 1500 | Validated |
Doxycycline | Antibacterial | Generic | LC/MS/MS | 10 | 7000 | Validated |
Doxycycline | Antibacterial | Generic | LC/MS/MS | 10 | 7000 | Validated |
Dronedarone+ Desbutyl Dronedarone | Antiarrhythmic | Generic | LC/MS/MS | 0.50 0.50 |
300 300 |
Validated |
Drospirenone | Progestogen | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Droxidopa | Parkinson's disease | Generic | LC/MS/MS | 10 | 6000 | Validated |
Droxidopa | Parkinson's disease | Generic | LC/MS/MS | 10 | 6000 | Validated |
Duloxetine | Antidepressant | Generic | LC/MS/MS | 0.4 | 150 | Validated |
Duloxetine | Antidepressant | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Dutastaride | 5-alpha-reductase inhibitor | Generic | LC/MS/MS | 0.1 | 25 | Validated |
Dutasteride | Benign prostatic hyperplasia | Generic | LC/MS/MS | 0.01 | 10 | Validated |
Dutasteride +Tamsulosin | BPH (Benign prostatic hyperplasia) | Generic | LC/MS/MS | 0.020 0.10 |
10 50 |
Validated |
Edaravone | Antioxidants | Generic | LC/MS/MS | 20 | 7000 | Validated |
Edoxaban | Factor Xa inhibitors | Generic | LC/MS/MS | 3 | 720 | Validated |
Edoxaban | Factor Xa inhibitors | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Efavirenz | Antiviral | Generic | LC/MS/MS | 50 | 9000 | Validated |
Efavirenz | Antiviral | Generic | LC/MS/MS | 30 | 6000 | Validated |
Eletriptan | Anti-Migraine | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Eliglustat | Gaucher's disease | Generic | LC/MS/MS | 0.1 | 100 | Validated |
Eliglustat | Gaucher's disease | Generic | LC/MS/MS | 0.1 | 100 | Validated |
Eltrombopag | Thrombocytopenia | Generic | LC/MS/MS | 50 | 30000 | Validated |
Empagliflozin | Antidiabetic | Generic | LC/MS/MS | 3 | 1200 | Validated |
Empagliflozin | Antidiabetic | Generic | LC/MS/MS | 1 | 300 | Validated |
Empagliflozin and Linagliptin | Antidiabetic | Generic | LC/MS/MS | 3 0.035 |
1200 14 |
Validated |
Emtricitabin | Antiviral | Generic | LC/MS/MS | 30 | 3000 | Validated |
Emtricitabine + Tenofovir |
Antiviral | Generic | LC/MS/MS | 20 4 |
4000 800 |
Validated |
Emtricitabine + Tenofovir Alafenamide | Antiviral | Generic | LC/MS/MS | 20 2 |
5000 500 |
Validated |
Enalapril + Enalaprilat |
Antihypertensive | Generic | LC/MS/MS | 5 2 |
1000 450 |
Validated |
Enalapril + Enalaprilate |
Antihypertensive | Generic | LC/MS/MS | 1 0.50 |
500 250 |
Validated |
Enalapril + Enalaprilate |
Antihypertensive | Generic | LC/MS/MS | 1 0.50 |
500 250 |
Validated |
Entacapone + Metabolite |
Parkinson's disease | Generic | LC/MS/MS | 50 | 6000 | Validated |
Entacapone + Metabolite |
Parkinson's disease | Generic | LC/MS/MS | 25 | 6000 | Validated |
E-Entacapone | Parkinson's disease | Generic | LC/MS/MS | 10 | 5000 | Validated |
Entecavir | Antiviral | Generic | LC/MS/MS | 0.04 | 20 | Validated |
Enzalutamide | Metastatic castration-resistant prostate cancer (CRPC) | Generic | LC/MS/MS | 10 | 10000 | Validated |
Enzalutamide | Metastatic castration-resistant prostate cancer (CRPC) | Generic | LC/MS/MS | 20 | 10000 | Validated |
Eplerenone | Chronic Heart Failure | Generic | LC/MS/MS | 10 | 4000 | Validated |
Eprosartan | Antihypertensive | Generic | LC/MS/MS | 30 | 4000 | Validated |
Eprosartan + Hydrochlorothiazide |
Antihypertensive Diuretic |
Generic | LC/MS/MS | 30 1 |
7500 500 |
Validated |
Eprosartan | Antihypertensive | Generic | LC/MS/MS | 30 | 6000 | Validated |
Erdosteine | Thiol derivative | Generic | LC/MS/MS | 15 | 3000 | Validated |
Erlotinib | Anticancer | Generic | LC/MS/MS | 12.5 | 2500 | Validated |
Erlotinib | Anticancer | Generic | LC/MS/MS | 1 | 2500 | Validated |
Erythromycin | Antibacterial | Generic | LC/MS/MS | 20 | 2000 | Validated |
Erythromycin | Antimicrobial | Generic | LC/MS/MS | 10 | 4000 | Validated |
Escitalopram | Antidepressant | Generic | LC/MS/MS | 0.3 | 200 | Validated |
Escitalopram | Antidepressant | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Escitalopram + S (+) Desmethylcitalopram |
Antidepressant | Generic | LC/MS/MS | 0.20 0.040 |
50 10 |
Validated |
Eslicarbazepine | Antiepileptic | Generic | LC/MS/MS | 100 | 30000 | Validated |
Esomeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 3500 | Validated |
Esomeprazole (Sensitive) | Proton pump inhibitor | Generic | LC/MS/MS | 5 | 3500 | Validated |
Esomeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 4000 | Validated |
Esomeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 2 | 800 | Validated |
Esomeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 2 | 800 | Validated |
Esomeprazole + Naproxen |
Proton pump inhibitor NSAID |
Generic | LC/MS/MS | 5 500 |
1500 150000 |
Validated |
Esomeprazole+ Naproxen |
Proton pump inhibitor NSAID |
Generic | LC/MS/MS | 2 500 |
600 150000 |
Validated |
Esomeprazole & Naproxen | Proton pump inhibitor NSAID |
Generic | LC/MS/MS | 2 150 |
2000 150000 |
Validated |
Ethinyl Esterdiol + Levonorgetral |
Oestrogen | Generic | LC/MS/MS | 0.004 0.10 |
0.50 20 |
Validated |
Ethosuximide | Anticonvulsant | Generic | LC/MS/MS | 50 | 20000 | Validated |
Ethosuximide | Antiepileptic | Generic | LC/MS/MS | 800 | 200000 | Validated |
Etodolac | Non-steroidal Anti-inflammatory | Generic | LC/MS/MS | 500 | 80000 | Validated |
Etodolac | Nonsteroidal anti-inflammatory | Generic | LC/MS/MS | 250 | 80000 | Validated |
Etoposide | Anticancer | Generic | LC/MS/MS | 20 | 8000 | Validated |
Etoricoxib | COX-2 selective inhibitor | Generic | LC/MS/MS | 10 | 5000 | Validated |
Etravirine | Antiviral | Generic | LC/MS/MS | 2 | 1200 | Validated |
Everolimus | Anticancer | Generic | LC/MS/MS | 0.3 | 200 | Validated |
Exemestane | Aromatase inhibitor, Anticancer | Generic | LC/MS/MS | 0.1 | 40 | Validated |
Ezetimib + Ezetimibe-O-beta-glucuronide |
Antihyperlipidemic | Generic | LC/MS/MS | 0.10 1 |
25 250 |
Validated |
Ezetimibe + Ezetimibe Phenoxy Glucuronide |
Antihyperlipidemic | Generic | LC/MS/MS | 0.10 1 |
30 300 |
Validated |
Ezetimibe(Unconjugated) | Antihyperlipidemic | Generic | LC/MS/MS | 0.125 | 20 | Validated |
Ezetimib (Total) | Antihyperlipidemic | Generic | LC/MS/MS | 1 | 200 | Validated |
Ezetimibe+ Ezetimibe Phenoxygluconoride |
Antihyperlipidemic | Generic | LC/MS/MS | 0.10 1 |
15 150 |
Validated |
Famotidine | Antihistamine (H2 Antagonist) | Generic | LC/MS/MS | 1 | 300 | Validated |
Febuxostat | Inhibitor of Xanthine Oxidase | Generic | LC/MS/MS | 50 | 10000 | Validated |
Felodipine | Antihypertensive | Generic | LC/MS/MS | 0.2 | 10 | Validated |
Felodipine | Calcium channel blocker | Generic | LC/MS/MS | 0.1 | 10 | Validated |
Felodipine | Antihypertensive | Generic | LC/MS/MS | 0.015 | 15 | Validated |
Fenofibric Acid | Antihyperlipidemic | Generic | LC/MS/MS | 25 | 10000 | Validated |
Fenofibric Acid | Antihyperlipidemic | Generic | LC/MS/MS | 50 | 20000 | Validated |
Fenofibric Acid | Antihyperlipidemic | Generic | LC/MS/MS | 50 | 20000 | Validated |
Fenoprofen | Non-steroidal Anti-inflammatory | Generic | LC/MS/MS | 250 | 100000 | Validated |
Fesoterodine + 5-Hydyroxy methyl tolterodine |
Urinary Iincontinence | Generic | LC/MS/MS | 0.001 0.02 |
0.750 15 |
Validated |
Fexofenadine | Antihistamine | Generic | LC/MS/MS | 8 | 1000 | Validated |
Fexofenadine | Antihistamine | Generic | LC/MS/MS | 4 | 2000 | Validated |
Fexofenadine | Antihistamine | Generic | LC/MS/MS | 4 | 2000 | Validated |
Fexofenadine + Pseudoephedrine |
Antihistamine | Generic | LC/MS/MS | 2 | 1500 | Validated |
Fexofenadine + Pseudoephedrine (Sensitive) |
Antihistamine | Generic | LC/MS/MS | 1 2 |
500 1000 |
Validated |
Flibanserin | HypoactiveSsexual Desire Disorder (HSDD) | Generic | LC/MS/MS | 4 | 1400 | Validated |
Fingolimod | Multiple sclerosis | Generic | LC/MS/MS | 0.01 | 5 | Validated |
Flecainide | Anti–arrhythmic | Generic | LC/MS/MS | 2 | 800 | Validated |
Flecainide | Anti–arrhythmic | Generic | LC/MS/MS | 2 | 800 | Validated |
Fluconazole | Antifungal | Generic | LC/MS/MS | 50 | 10000 | Validated |
Fluconazole | Antifungal | Generic | LC/MS/MS | 20 | 8000 | Validated |
Flucytosine | Antioxidant | Generic | LC/MS/MS | 0.1 | 30 | Validated |
Flucytosine | Antifungal | Generic | LC/MS/MS | 0.1 | 30 | Validated |
Fludarabine | Purine analogs | Generic | LC/MS/MS | 6 | 2000 | Validated |
Fludrocortisone | Glucocorticoid | Generic | LC/MS/MS | 0.025 | 2.5 | Validated |
Fludrocortisone | Glucocorticoid | Generic | LC/MS/MS | 0.01 | 1.5 | Validated |
Fluoxetine | Antidepressant | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Fluoxetine + Norfluoxetine |
Antidepressant | Generic | LC/MS/MS | 2 | 400 | Validated |
Fluoxetine | Antidepressant | Generic | LC/MS/MS | 1 | 200 | Validated |
Fluphenazine | Antipsychotic | Generic | LC/MS/MS | 0.02 | 5 | Validated |
Free Dabigatran | Thrombin Inhibitor | Generic | LC/MS/MS | 1 | 400 | Validated |
Fulvestrant | Anticancer | Generic | LC/MS/MS | 0.1 | 25 | Validated |
Fulvestrant | Anticancer | Generic | LC/MS/MS | 0.5 | 500 | Validated |
Furosemide | Diuretic | Generic | LC/MS/MS | 20 | 6000 | Validated |
Gabapentin | Anticonvulsant | Generic | LC/MS/MS | 40 | 10000 | Validated |
Gabapentin | Anticonvulsant | Generic | LC/MS/MS | 40 | 6000 | Validated |
Gabapentin | Anticonvulsant | Generic | LC/MS/MS | 40 | 12000 | Validated |
Galantamine | Alzheimer's disease | Generic | LC/MS/MS | 0.25 | 150 | Validated |
Gefitinib | Anticancer | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Gefitinib | Anticancer | Generic | LC/MS/MS | 1.5 | 450 | Validated |
Gilteritinib | Kinase inhibitors | Generic | LC/MS/MS | 0.2 | 130 | Validated |
Glibenclamide (Glyburide) | Antidiabetic | Generic | LC/MS/MS | 1 | 500 | Validated |
Glibenclamide (Glyburide) | Antidiabetic | Generic | LC/MS/MS | 2 | 800 | Validated |
Glibenclamide + Metformin |
Antidiabetic | Generic | LC/MS/MS | 2 10.0 |
600 3000 |
Validated |
Gliclazide | Antidiabetic | Generic | LC/MS/MS | 50 | 5000 | Validated |
Gliclazide | Antidiabetic | Generic | LC/MS/MS | 50 | 12000 | Validated |
Glimepiride | Antidiabetic | Generic | LC/MS/MS | 1 | 500 | Validated |
Glimpiride | Antidiabetic | Generic | LC/MS/MS | 1 | 500 | Validated |
Glimepiride | Antidiabetic | Generic | LC/MS/MS | 2 | 800 | Validated |
Glimepiride | Antidiabetic | Generic | LC/MS/MS | 2 | 800 | Validated |
Glimepiride | Antidiabetic | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Glipizide | Antidiabetic | Generic | LC/MS/MS | 5 | 2000 | Validated |
Glycopyrronium | Anticholinergic | Generic | LC/MS/MS | 0.50 pg/mL | 500 pg/mL | Validated |
Griseofulvin | Antifungal | Generic | LC/MS/MS | 10 | 4000 | Validated |
Granisetron | Anti–emetic | Generic | LC/MS/MS | 0.15 | 15 | Validated |
Granisetron | Anti–emetic | Generic | LC/MS/MS | 0.1 | 30 | Validated |
Granisetron | Anti–emetic | Generic | LC/MS/MS | 0.15 | 150 | Validated |
Griseofulvin | Antifungal | Generic | LC/MS/MS | 10 | 5000 | Validated |
Guaifenesin | Expectorant | Generic | LC/MS/MS | 43.77 | 5605.77 | Validated |
Guaifenesin | Expectorant | Generic | LC/MS/MS | 15 | 6000 | Validated |
Guaifenesin | Expectorant | Generic | LC/MS/MS | 12.5 | 5000 | Validated |
Guanfacine | Antihypertensive | Generic | LC/MS/MS | 0.025 | 10 | Validated |
Guanfacine | Antihypertensive | Generic | LC/MS/MS | 0.05 | 20 | Validated |
Hydralazine | Antihypertensive | Generic | LC/MS/MS | 0.2 | 200 | Validated |
Hydrochlorothiazide | Diuretic | Generic | LC/MS/MS | 5 | 500 | Validated |
Hydrochlorothiazide | Diuretic | Generic | LC/MS/MS | 1 | 500 | Validated |
Hydrochlorothiazide | Antihypertensive | Generic | LC/MS/MS | 1 | 250 | Validated |
Hydrochlorothiazide + Irbesartan |
Antihypertensive Diuretic |
Generic | LC/MS/MS | 1 30 |
250 7500 |
Validated |
Hydrochlorothiazine + Telmisartan |
Antihypertensive | Generic | LC/MS/MS | 1.50 5 |
300 1000 |
Validated |
Hydrochlorothiazide + Metoprolol |
Antihypertensive | Generic | LC/MS/MS | 1 0.15 |
500 75 |
Validated |
Hydrocortisone | Glucocorticoid | Generic | LC/MS/MS | 0.5 | 1000 | Validated |
Hydrocortisone (Free ) | Glucocorticoid | Generic | LC/MS/MS | 0.1 | 80 | Validated |
Hydrocortisone (Free ) | Glucocorticoid | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Hydrocortisone (Total) | Glucocorticoid | Generic | LC/MS/MS | 1 | 500 | Validated |
Hydroxycarbamide (Hydroxyurea) | Anticancer | Generic | LC/MS/MS | 100 | 30000 | Validated |
Hydroxycarbamide(Hydroxyurea) | Antimetabolites | Generic | LC/MS/MS | 100 | 30000 | Validated |
Hydroxychloroquine | Antimalarial | Generic | LC/MS/MS | 2 | 600 | Validated |
Ibrutinib | Anticancer | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Ibrutinib | Anticancer | Generic | LC/MS/MS | 1 | 600 | Validated |
Ibrutinib and Dihydrodiol Ibrutinib | Anticancer | Generic | LC/MS/MS | 0.300 0.500 |
450 750 |
Validated |
Ibuprofen | NSAID | Generic | LC/MS/MS | 500 | 100000 | Validated |
Ibuprofen | NSAID | Generic | LC/MS/MS | 150 | 30000 | Validated |
Ibuprofen | NSAID | Generic | LC/MS/MS | 250 | 100000 | Validated |
Ibuprofen and Paracetamol | Anti-inflammatory & antipyretics | Generic | LC/MS/MS | 100 30 |
30000 9000 |
Validated |
Idelasisib | Chronic lymphocytic leukemia | Generic | LC/MS/MS | 10 | 4000 | Validated |
Imatinib | Anticancer | Generic | LC/MS/MS | 25 | 8000 | Validated |
Imatinib | Anticancer | Generic | LC/MS/MS | 25 | 6000 | Validated |
Imatinib + N-Desmethyl Imatinib |
Anticancer | Generic | LC/MS/MS | 20 2 |
10000 1000 |
Validated |
Indapamide | Antihypertensive | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Indapamide | Antihypertensive | Generic | LC/MS/MS | 1 | 500 | Validated |
Indomethacin | Nonsteroidal anti-inflammatory | Generic | LC/MS/MS | 25 | 5000 | Validated |
Indoramin | Antihypertensive | Generic | LC/MS/MS | 0.04 | 80 | Validated |
Ipratropium | Asthma | Generic | LC/MS/MS | 0.60 pg/mL | 180 pg/mL | Validated |
Irbesartan + Hydrochlorothiazide |
Antihypertensive Diuretic |
Generic | LC/MS/MS | 10 1 |
5000 500 |
Validated |
Irbesartan | Antihypertensive | Generic | LC/MS/MS | 30 | 7500 | Validated |
Iron | Iron Defficiency Anaemia | Generic | LC/MS/MS | 400 | 20000 | Validated |
Isosorbide 5-mononitrate | Angina Pectoris, Congestive Heart Failure |
Generic | LC/MS/MS | 10 | 1000 | Validated |
Isotretinoin | Anti-acne | Generic | LC/MS/MS | 0.5 | 2000 | Validated |
Isotretinoin | Anti-acne | Generic | LC/MS/MS | 0.5 | 1000 | Validated |
Itraconazole | Antifungal | Generic | LC/MS/MS | 2 | 600 | Validated |
Itraconazole | Antifungal | Generic | LC/MS/MS | 1 | 1000 | Validated |
Itraconazole + Hydroxy Itraconazole |
Antifungal | Generic | LC/MS/MS | 2 | 600 | Validated |
Ivabradine | Heart rate lowering agent | Generic | LC/MS/MS | 0.25 | 100 | Validated |
Ivabradine + N-desmethyi ivabradine |
Heart rate lowering agent | Generic | LC/MS/MS | 0.20 0.050 |
100 25 |
Validated |
Ivacaftor | Cystic fibrosis | Generic | LC/MS/MS | 2 | 2000 | Validated |
Ivacaftor+Tezacaftor+Elexacaftor | CFTR | Generic | LC/MS/MS | 1 7 10 |
1000 7000 10000 |
Validated |
Ivermectin | Anthelmintics | Generic | LC/MS/MS | 0.2 | 80 | Validated |
Ketoprofen | Antimetabolites | Generic | LC/MS/MS | 20 | 10000 | Validated |
Ketorolac | Antihistamine | Generic | LC/MS/MS | 10 | 2000 | Validated |
Ketotifen | NSAID | Generic | LC/MS/MS | 0.002 | 1 | Validated |
Lacosamide | Antiepileptic | Generic | LC/MS/MS | 50 | 10000 | Validated |
Labetalol | Antihypertensive | Generic | LC/MS/MS | 1 | 500 | Validated |
Lacosamide | Antiepileptic | Generic | LC/MS/MS | 50 | 20000 | Validated |
Lamivudine | Antiviral | Generic | LC/MS/MS | 60 | 6000 | Validated |
Lamivudine | Antiviral | Generic | LC/MS/MS | 20 | 6000 | Validated |
Lamivudine + Tenofovir |
Antiviral | Generic | LC/MS/MS | 2 5 |
4000 1000 |
Validated |
Lamivudine + Zidovudine |
Antiviral | Generic | LC/MS/MS | 40 60 |
4000 6000 |
Validated |
Lamivudine + Abacavir |
Antiviral | Generic | LC/MS/MS | 55 30 |
11000 6000 |
Validated |
Lamivudine + Nevirapine + Zidovudine |
Antiviral | Generic | LC/MS/MS | 50 | 6000 | Validated |
Lamuvudine + Nevirapine + Zidovudine |
Antiviral | Generic | LC/MS/MS | 40 50 60 |
4000 5000 6000 |
Validated |
Lamotrigine | Anticonvulsant, Anti–epileptic | Generic | LC/MS/MS | 40 | 10000 | Validated |
Lamotrigine | Anticonvulsant, Anti–epileptic | Generic | LC/MS/MS | 5 | 4000 | Validated |
Lamotrigine | Anticonvulsant, Anti–epileptic | Generic | LC/MS/MS | 20 | 10000 | Validated |
Lansoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 5 | 2000 | Validated |
Lansoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 2 | 2000 | Validated |
Lansoprazole | Proton-pump inhibitor | Generic | LC/MS/MS | 5 | 2500 | Validated |
Lansoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 2.5 | 2500 | Validated |
Lapatinib | Anticancer | Generic | LC/MS/MS | 10 | 5000 | Validated |
Lapatinib | Anticancer | Generic | LC/MS/MS | 3 | 1500 | Validated |
Larotrectinib | Kinase inhibitors | Generic | LC/MS/MS | 3 | 1500 | Validated |
Ledipasvir + Sofosbuvir |
Antiviral | Generic | LC/MS/MS | 2 3 |
1000 1500 |
Validated |
Lenalidomide | Anticancer (Multiple myeloma) | Generic | LC/MS/MS | 2 | 1000 | Validated |
Lenalidomide | Anticancer (Multiple myeloma) | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Lenalidomide | Anticancer (Multiple myeloma) | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Lenvatinib | Anticancer | Generic | LC/MS/MS | 0.4 | 400 | Validated |
Letrozole | Anticancer | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Letrozole | Breast Cancer | Generic | LC/MS/MS | 1 | 400 | Validated |
Leuprolide (Leuprorelin) | Prostate cancer, Breast cancer | Generic | LC/MS/MS | 0.05 | 50 | Validated |
Leuprolide (Leuprorelin) | Prostate cancer, Breast cancer | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Leuprolide | Prostate cancer, Breast cancer | Generic | LC/MS/MS | 0.02 | 120 | Validated |
Leuprolide (Leuprorelin) | Prostate cancer, Breast cance | Generic | LC/MS/MS | 0.02 | 120 | Validated |
Leuprolide | Prostate cancer, Breast cancer | Generic | LC/MS/MS | 0.02 | 120 | Validated |
Levetiracetam | Anti–epileptic | Generic | LC/MS/MS | 300 | 60000 | Validated |
Levocarnitine | Primary systemic carnitine deficiency | Generic | LC/MS/MS | 100 | 20000 | Validated |
Levocetirizine | Non-sedative antihistamine | Generic | LC/MS/MS | 10 | 600 | Validated |
Levocetrizine | Antihistamines | Generic | LC/MS/MS | 2 | 600 | Validated |
Levofloxacin | Antibacterial | Generic | LC/MS/MS | 100 | 16000 | Validated |
Levofloxacin | Antibacterial | Generic | LC/MS/MS | 80 | 20000 | Validated |
Levofloxacin | Antibacterial | Generic | LC/MS/MS | 20 | 4000 | Validated |
Levomepromazine | Antipsychotic | Generic | LC/MS/MS | 0.025 | 15 | Validated |
Levosalbutamol | Ashtma | Generic | LC/MS/MS | 0.005 | 1 | Validated |
Levothyroxine | Thyroid Hormone Defficiency | Generic | LC/MS/MS | 10 | 1000 | Validated |
Levothyroxine + Liothyronine |
Thyroid Hormone Defficiency | Generic | LC/MS/MS | 20 0.30 |
1000 15 |
Validated |
Levothyroxine + Liothyronine |
Thyroid Hormone Defficiency | Generic | LC/MS/MS | 20 0.30 |
800 12 |
Validated |
Levothyroxine & Liothyronine | Thyroid Hormone Defficiency | Generic | LC/MS/MS | 10 0.200 |
500 10 |
Validated |
Lidocaine | Local Anesthetic | Generic | LC/MS/MS | 0.2 | 200 | Validated |
Lidocaine + Prilocaine |
Local Anesthetic | Generic | LC/MS/MS | 0.60 0.40 |
300 200 |
Validated |
Linagliptin | Antidiabetic | Generic | LC/MS/MS | 0.035 | 14 | Validated |
Linezolid | Antibiotic | Generic | LC/MS/MS | 100 | 24000 | Validated |
Lisinopril | Antihypertensive | Generic | LC/MS/MS | 1 | 200 | Validated |
Lisinopril | Antihypertensive | Generic | LC/MS/MS | 0.5 | 60 | Validated |
Lisinopril | Antihypertensive | Generic | LC/MS/MS | 0.2 | 200 | Validated |
Lisinopril | Antihypertensive | Generic | LC/MS/MS | 1 | 700 | Validated |
Lithium | Antidepressant | Generic | LC/MS/MS | 50 | 5000 | Validated |
Lithium | Antidepressant | Generic | LC/MS/MS | 40 | 8000 | Validated |
Loperamide | Antidiarrheal | Generic | LC/MS/MS | 0.01 | 4 | Validated |
Loperamide | Antidiarrheal | Generic | LC/MS/MS | 0.005 | 6 | Validated |
Loperamide + N-Desmethyl Loperamide |
Antidiarrheal | Generic | LC/MS/MS | 0.010 0.010 |
4 4 |
Validated |
Lopinavir + Ritonavir |
Antiretroviral | Generic | LC/MS/MS | 30 3 |
15000 1500 |
Validated |
Loratadine + Desloratadine |
Antihistamine | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Loratadine | Antihistamine | Generic | LC/MS/MS | 0.075 | 25 | Validated |
Lorcaserin | Weight Loss | Generic | LC/MS/MS | 0.4 | 200 | Validated |
Losartan | Angiotensin II Receptor Antagonist | Generic | LC/MS/MS | 1 | 500 | Validated |
Lumefantrine | Antimalarial | Generic | LC/MS/MS | 50 | 20000 | Validated |
Lumafantrine | Antimalarial | Generic | LC/MS/MS | 50 | 30000 | Validated |
Lumateperone | Atypical antipsychotics | Generic | LC/MS/MS | 0.1 | 80 | Validated |
Lurasidone | Antipsychotic | Generic | LC/MS/MS | 0.25 | 150 | Validated |
Lurasidone | Antipsychotic | Generic | LC/MS/MS | 0.25 | 150 | Validated |
Magnesium | Hypomagnesaemia | Generic | LC/MS/MS | 2000 | 150000 | Validated |
Magnesium | Hypomagnesaemia | Generic | LC/MS/MS | 2000 | 350000 | Validated |
Macitentan | Antihypertensive | Generic | LC/MS/MS | 1 | 500 | Validated |
Maraviroc | Antiviral | Generic | LC/MS/MS | 0.5 | 500 | Validated |
Mavoglurant | Indoles and derivatives | Generic | LC/MS/MS | 2 | 2500 | Validated |
Mebendazole | Anthelmintic | Generic | LC/MS/MS | 0.02 | 30 | Validated |
Meclizine | Antihistamine | Generic | LC/MS/MS | 0.5 | 300 | Validated |
Mefenamic Acid (Sensitive) | Non-steroidal Anti-inflammatory | Generic | LC/MS/MS | 40.5 | 12000 | Validated |
Mefenamic Acid (Sensitive) | Non-steroidal Anti-inflammatory | Generic | LC/MS/MS | 20 | 11000 | Validated |
Mefenamic acid | Non steroial anti inflammatory | Generic | LC/MS/MS | 30 | 12000 | Validated |
Melatonin | Acetamides | Generic | LC/MS/MS | 0.05 | 30 | Validated |
Meloxicam | NSAID | Generic | LC/MS/MS | 20 | 8000 | Validated |
Memantine | Anti-Alzheimer's | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Mexiletine | Antiarrhythmic | Generic | LC/MS/MS | 2 | 1000 | Validated |
Mercaptopurine | Immunosuppressant | Generic | LC/MS/MS | 0.5 | 80 | Validated |
Mesalamine | Anti-inflammatory | Generic | LC/MS/MS | 2 | 3500 | Validated |
Mesalamine | Anti-inflammatory | Generic | LC/MS/MS | 2 | 2000 | Validated |
Mesalamine | Anti-inflammatory | Generic | LC/MS/MS | 2 | 2000 | Validated |
Mesalamine | Anti-inflammatory | Generic | LC/MS/MS | 25 | 12500 | Validated |
Mesalamine & Its Metabolite | Anti-inflammatory | Generic | LC/MS/MS | 50 100 |
10000 20000 |
Validated |
Mesalamine & N-Acetyl Mesalamine | Anti-inflammatory | Generic | LC/MS/MS | 1000 | 1000000 | Validated |
Metaxalone | Muscle Relaxant | Generic | LC/MS/MS | 10 | 5000 | Validated |
Metformin | Antidiabetic | Generic | LC/MS/MS | 40 | 7500 | Validated |
Metformin | Antidiabetic | Generic | LC/MS/MS | 40 | 7500 | Validated |
Metformin | Antidiabetic | Generic | LC/MS/MS | 20 | 7500 | Validated |
Metformin | Antidiabetic | Generic | LC/MS/MS | 4 | 800 | Validated |
Metformin | Antidiabetic | Generic | LC/MS/MS | 2 | 250 | Validated |
Metformin & Linagliptin | Anti-diabetic | Generic | LC/MS/MS | 18 0.04 |
3600 8 |
Validated |
Metformin + Sitagliptin | Antidiabetic | Generic | LC/MS/MS | 10 2 |
4000 800 |
Validated |
Metformin + Vildagliptin |
Antidiabetic | Generic | LC/MS/MS | 10 2 |
4000 800 |
Validated |
Metformin + Vildagliptin |
Antidiabetic | Generic | LC/MS/MS | 5 2 |
4000 1600 |
Validated |
Metformin and Dapagliflozin | Antidiabetic | Generic | LC/MS/MS | 12 2 |
3000 500 |
Validated |
Methenamine | Urinary Tract Infection | Generic | LC/MS/MS | 0.05 | 20 | Validated |
Methimazole | Antithyroid | Generic | LC/MS/MS | 1 | 500 | Validated |
Methocarbamol | Musculoskeletal relaxant | Generic | LC/MS/MS | 100 | 30000 | Validated |
Methotrexate | Anticancer | Generic | LC/MS/MS | 1 | 250 | Validated |
Methotrexate | Anticancer | Generic | LC/MS/MS | 2 | 600 | Validated |
Methoxsalen | Dermatological | Generic | LC/MS/MS | 1 | 200 | Validated |
Methoxsalen (Sensitive) | Dermatological | Generic | LC/MS/MS | 0.1 | 100 | Validated |
Methyl Ergonovine | Postpartum Hemorrhage | Generic | LC/MS/MS | 0.04 | 10 | Validated |
Methylphenidate | CNS Stimulant | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Methyl Prednisolone | Corticosteroid hormone | Generic | LC/MS/MS | 0.05 | 40 | Validated |
Methyl Prednisolone | Glucocorticoid | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Methyl Prednisolone | Glucocorticoid | Generic | LC/MS/MS | 5 | 4000 | Validated |
Metolazone | Diuretic | Generic | LC/MS/MS | 0.15 | 150 | Validated |
Metolazone | Diuretic | Generic | LC/MS/MS | 0.2 | 250 | Validated |
Metopimazine + Metopimazine Acid |
Antiemetic | Generic | LC/MS/MS | 0.20 0.40 |
100 200 |
Validated |
Metoprolol | Antihypertensive | Generic | LC/MS/MS | 0.3 | 300 | Validated |
Metoprolol | Antihypertensive | Generic | LC/MS/MS | 0.3 | 300 | Validated |
Metoprolol | Antihypertensive | Generic | LC/MS/MS | 0.3 | 300 | Validated |
Metronidazole | Antiamoebic | Generic | LC/MS/MS | 100 | 40000 | Validated |
Metronidazole | Antiamoebic | Generic | LC/MS/MS | 100 | 40000 | Validated |
Metronidazole | Antiamoebic | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Metronidazole + Tetracycline | Antimicrobials | Generic | LC/MS/MS | 0.100 0.010 |
20 2 |
Validated |
Midazolam + 1-Hydroxy Midazolam |
Anxiolytic | Generic | LC/MS/MS | 0.30 0.10 |
60 20 |
Validated |
Midostaurin | Antineoplastic agents | Generic | LC/MS/MS | 5 | 2500 | Validated |
Minocycline | Antibiotic | Generic | LC/MS/MS | 10 | 3000 | Validated |
Minocycline | Antibiotic | Generic | LC/MS/MS | 10 | 3000 | Validated |
Mirabegron | Urinary incontinence | Generic | LC/MS/MS | 0.1 | 80 | Validated |
Mirtazapine | Antidepressants | Generic | LC/MS/MS | 0.3 | 240 | Validated |
Mometasone | Corticosteroid, Asthma | Generic | LC/MS/MS | 0.20 pg/mL | 30 pg/mL | Validated |
Mono Methyl Fumarate | Multiple Sclerosis | Generic | LC/MS/MS | 10 | 5000 | Validated |
Montalukast+ Fexofenadin |
Leukotriene receptor antagonist Antihistamine | Generic | LC/MS/MS | 2 | 1000 | Validated |
Montelukast | Lukotriene receptor antagonist | Generic | LC/MS/MS | 5 | 1000 | Validated |
Montelukast | Lukotriene receptor antagonist | Generic | LC/MS/MS | 1 | 400 | Validated |
Moxifloxacin | Antibacterial | Generic | LC/MS/MS | 40 | 5000 | Validated |
Moxifloxacin | Antibacterial | Generic | LC/MS/MS | 40 | 10000 | Validated |
Moxifloxacin | Antibacterial | Generic | LC/MS/MS | 30 | 15000 | Validated |
Mycophenolic acid | Immunosuppressant | Generic | LC/MS/MS | 300 | 50000 | Validated |
Mycophenolic acid | Immunosuppressant | Generic | LC/MS/MS | 40.5 | 20000 | Validated |
Mycophenolate Acid | Immunosuppressant | Generic | LC/MS/MS | 40 | 20000 | Validated |
Mycophenolic Acid | Immunosuppressant | Generic | LC/MS/MS | 200 | 50000 | Validated |
Mycophenolic Acid | Immunosuppressant | Generic | LC/MS/MS | 40 | 20000 | Validated |
Mycophenolic Acid | Immunosuppressant | Generic | LC/MS/MS | 60 | 30000 | Validated |
Mycophenolic acid | Immunosuppressant | Generic | LC/MS/MS | 100 | 50000 | Validated |
Mycophnolic Acid | Immunosuppressant | Generic | LC/MS/MS | 60 | 30000 | Validated |
Mycophenolate Mofetil | Immunosuppressant | Generic | LC/MS/MS | 20 | 800 | Validated |
Mycophenolate Mofetil | Immunosuppressant | Generic | LC/MS/MS | 0.1 | 16 | Validated |
Mycophenolate Mofetil | Immunosuppressant | Generic | LC/MS/MS | 0.01 | 10 | Validated |
Nadolol | Antihypertensive | Generic | LC/MS/MS | 1 | 600 | Validated |
Nafithromycin | Antibiotic | Generic | LC/MS/MS | 10 | 5000 | Validated |
Naltrexone + 6ß Naltrexone |
Opioid antagonist | Generic | LC/MS/MS | 0.10 0.50 |
35 175 |
Validated |
Naltrexone and its Metabolite | Opioid antagonist | Generic | LC/MS/MS | 0.005 0.050 |
5.000 50 |
Validated |
Naproxen | NSAID | Generic | LC/MS/MS | 10 | 10000 | Validated |
Naproxen | Analgesic | Generic | LC/MS/MS | 500 | 150000 | Validated |
Naproxen | NSAID | Generic | LC/MS/MS | 400 | 200000 | Validated |
Naratriptan | Anti-migraine | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Naratriptan | Anti-migraine | Generic | LC/MS/MS | 0.05 | 25 | Validated |
Nateglinide | Antidiabetic | Generic | LC/MS/MS | 50 | 12000 | Validated |
Nebivolol | Antihypertensive | Generic | LC/MS/MS | 0.05 | 5 | Validated |
Nebivolol | Antihypertensive | Generic | LC/MS/MS | 0.04 | 15 | Validated |
Nebivolol | Antihypertensive | Generic | LC/MS/MS | 0.03 | 40 | Validated |
Nefopam | Analgesic | Generic | LC/MS/MS | 1 | 200 | Validated |
Nefopam | Analgesic | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Nevirapine | Antiviral | Generic | LC/MS/MS | 50 | 5000 | Validated |
Nicardipine | Antihypertensive | Generic | LC/MS/MS | 0.2 | 130 | Validated |
Nifedipine | Antihypertensive | Generic | LC/MS/MS | 0.4 | 200 | Validated |
Nifedipine | Antihypertensive | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Nifedipine | Antihypertensive | Generic | LC/MS/MS | 0.25 | 100 | Validated |
Nifedipine | Antihypertensive | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Nilutamide | Antiandrogen | Generic | LC/MS/MS | 40 | 8000 | Validated |
Nilotinib | Anticancer | Generic | LC/MS/MS | 6 | 3000 | Validated |
Nilotinib | Anticancer | Generic | LC/MS/MS | 12 | 6000 | Validated |
Nilotinib | Anticancer | Generic | LC/MS/MS | 3 | 1800 | Validated |
Nimodipine | Antihypertensive | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Nintedanib | Idiopathic pulmonary fibrosis (IPF) | Generic | LC/MS/MS | 0.1 | 30 | Validated |
Nintedanib | Anti cancer | Generic | LC/MS/MS | 0.3 | 120 | Validated |
Nitisinone | Hereditary tyrosinemia type 1 (HT-1) | Generic | LC/MS/MS | 10 | 10000 | Validated |
Nitrofurantoin | Antibiotic | Generic | LC/MS/MS | 10 | 1500 | Validated |
Nitrofurantoin | Antibiotic | Generic | LC/MS/MS | 2 | 600 | Validated |
Nitrofurantoin | Antibiotic | Generic | LC/MS/MS | 0.75 | 1500 | Validated |
Nitrofurantoin | Antibiotic | Generic | LC/MS/MS | 0.75 | 1500 | Validated |
Nizatidine | Antihistamine | Generic | LC/MS/MS | 20 | 5000 | Validated |
Nomogestrel Acetate | Synthetic progestogen | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Norethisterone (Norethindrone) | Progestogen | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Norfloxacin | Antibacterial | Generic | LC/MS/MS | 25 | 8000 | Validated |
Nortriptyline | Antidepressant | Generic | LC/MS/MS | 0.5 | 220 | Validated |
Nortriptyline | Antidepressant | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Nortryptiline + E-10-Hydroxy Nortryptiline |
Antidepressant | Generic | LC/MS/MS | 0.10 0.20 |
50 100 |
Validated |
Obeticholic acid | Farnesoid X receptor agonists | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Octreotide | Growth hormone producing tumors | Generic | LC/MS/MS | 0.05 | 15 | Validated |
Octreotide | Growth hormone producing tumors | Generic | LC/MS/MS | 0.02 | 10 | Validated |
Ofloxacin | Antibacterial | Generic | LC/MS/MS | 25 | 8000 | Validated |
Olanzapine | Antipsychotic | Generic | LC/MS/MS | 0.5 | 50 | Validated |
Olaparib | Anticancer | Generic | LC/MS/MS | 50 | 20000 | Validated |
Olmesartan | Angiotensin II receptor antagonist | Generic | LC/MS/MS | 10 | 3000 | Validated |
Olmesartan+ Hydrochlorothiazide | Angiotensin II receptor antagonist Diuretic |
Generic | LC/MS/MS | 10 1.00 |
3000 300 |
Validated |
Olanzepine | Antipsychotic | Generic | LC/MS/MS | 0.1 | 30 | Validated |
Olanzapine | Antipsychotic | Generic | LC/MS/MS | 0.3 | 120 | Validated |
Olsalazine | Ulcerative colitis | Generic | LC/MS/MS | 20 | 2000 | Validated |
Omeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 5 | 2000 | Validated |
Omeprazole | Proton Pump Inhibitor | Generic | LC/MS/MS | 2 | 2000 | Validated |
Ondansetron | Anti–emetic | Generic | LC/MS/MS | 0.2 | 80 | Validated |
Ondansetron | Anti–emetic | Generic | LC/MS/MS | 0.2 | 80 | Validated |
Orphenadrine | Antihistamine | Generic | LC/MS/MS | 4 | 800 | Validated |
Orphenadrine | Antihistamine | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Oseltamivir + Oseltamivir Carobxylate |
Antiviral | Generic | LC/MS/MS | 0.50 2 |
250 1000 |
Validated |
Oseltamivir + Oseltamivir Carboxylate |
Antiviral | Generic | LC/MS/MS | 0.50 2 |
200 800 |
Validated |
Osimertinib | Anticancer | Generic | LC/MS/MS | 0.25 | 200 | Validated |
Ospemifene | Dyspareunia | Generic | LC/MS/MS | 5 | 2000 | Validated |
Oxaprozin Total | NSAID | Generic | LC/MS/MS | 500 | 160000 | Validated |
Oxazepam | Benzodiazepines | Generic | LC/MS/MS | 3 | 3000 | Validated |
Oxcarbazepine + 10, 11-Dihydro-10-hydroxy-Carbamazepine |
Anticonvulsant | Generic | LC/MS/MS | 20 75 |
4000 15000 |
Validated |
Oxybutynin + Metabolite- N-Desethyl Oxybutynin |
Anticholinergic | Generic | LC/MS/MS | 0.05 0.50 |
10 100 |
Validated |
Oxybutynin + N-Desethyl Oxybutynin |
Anticholinergic | Generic | LC/MS/MS | 0.050 0.20 |
50 200 |
Validated |
Ozanimod | Phosphate receptor modulators | Generic | LC/MS/MS | 3pg/mL | 600pg/mL | Validated |
Paclitaxel (Total) | Anticancer | Generic | LC/MS/MS | 5 | 15000 | Validated |
Paclitaxel (Total) | Anticancer | Generic | LC/MS/MS | 80 | 40000 | Validated |
Palbociclib | Anticancer | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Paliperidone | Antipsychotic | Generic | LC/MS/MS | 0.1 | 150 | Validated |
Paliperidone | Antipsychotic | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Paliperidone | Antipsychotic | Generic | LC/MS/MS | 0.05 | 50 | Validated |
Paliperidone | Antipsychotic | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Paliperidone | Antipsychotic | Generic | LC/MS/MS | 0.2 | 120 | Validated |
Palonosetron | 5-HT3 receptor antagonists | Generic | LC/MS/MS | 0.01 | 15 | Validated |
Pantoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 15 | 5000 | Validated |
Pantoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 6000 | Validated |
Pantoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 8000 | Validated |
Pantoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 8000 | Validated |
Pantoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 8000 | Validated |
Paracetamol | Antipyretic, Analgesic | Generic | LC/MS/MS | 0.2 | 60 | Validated |
Paroxetine | Antidepressant | Generic | LC/MS/MS | 0.4 | 200 | Validated |
Paroxetine | Antidepressant | Generic | LC/MS/MS | 0.4 | 60 | Validated |
Paroxetine | Antidepressant | Generic | LC/MS/MS | 0.04 | 24 | Validated |
Pazopanib | Anticancer | Generic | LC/MS/MS | 100 | 40000 | Validated |
Pazopanib | Anticancer | Generic | LC/MS/MS | 100 | 80000 | Validated |
Pazopanib | Anticancer | Generic | LC/MS/MS | 300 | 150000 | Validated |
Pazopanib | Anticancer | Generic | LC/MS/MS | 300 | 150000 | Validated |
Pazopanib | Anticancer | Generic | LC/MS/MS | 200 | 80000 | Validated |
Pemetrexed | Lung Cancer | Generic | LC/MS/MS | 500 | 200000 | Validated |
Pemigatinib | Kinase inhibitors | Generic | LC/MS/MS | 1 | 400 | Validated |
Pentoxyfylline + Hydroxy Pentoxyfylline + Pentoxyfylline acid |
Hemorrheologic agents | Generic | LC/MS/MS | 1 2 5 |
400 800 2000 |
Validated |
Perampanel | Antiepileptic | Generic | LC/MS/MS | 1 | 1000 | Validated |
Perindropril | Antihypertensive | Generic | LC/MS/MS | 1 | 300 | Validated |
Perindropril+ Perindoprilat | Antihypertensive | Generic | LC/MS/MS | 1 0.20 |
300 60 |
Validated |
Phenobarbital | Antiepileptic | Generic | LC/MS/MS | 10 | 4000 | Validated |
Phenobarbital | Antiepileptic | Generic | LC/MS/MS | 500 | 100000 | Validated |
Phenobarbital | Antiepileptic | Generic | LC/MS/MS | 10 | 5000 | Validated |
Phenobarbital | Antiepileptic | Generic | LC/MS/MS | 30 | 9000 | Validated |
Phenytoin | Antiepileptic | Generic | LC/MS/MS | 10 | 5000 | Validated |
Phenytoin | Antiepileptic | Generic | LC/MS/MS | 60 | 12000 | Validated |
Phloroglucinol | Antispasmodic | Generic | LC/MS/MS | 10 | 2500 | Validated |
Phloroglucinol | Antispasmodic | Generic | LC/MS/MS | 10 | 2500 | Validated |
Pimozide | Antipsychotic | Generic | LC/MS/MS | 0.02 | 5 | Validated |
Pindolol | Beta Blocker | Generic | LC/MS/MS | 1 | 400 | Validated |
Pioglitazone+ Hydroxy Pioglitazone M IV | Antihyperglycemic, antidiabetic | Generic | LC/MS/MS | 10 5 |
3000 1500 |
Validated |
Piperaquine | Antimalarial | Generic | LC/MS/MS | 2 | 300 | Validated |
Piribedil | Antiparkinsonian | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Pirfenidone | Idiopathic pulmonary fibrosis (IPF) | Generic | LC/MS/MS | 50 | 25000 | Validated |
Pirfenidone | Idiopathic pulmonary fibrosis (IPF) | Generic | LC/MS/MS | 50 | 30000 | Validated |
Pirfenidone | Idiopathic pulmonary fibrosis (IPF) | Generic | LC/MS/MS | 10 | 10000 | Validated |
Piroxicam | NSAID | Generic | LC/MS/MS | 10 | 10000 | Validated |
Pomalidomide | Anticancer (Multiple Myeloma) | Generic | LC/MS/MS | 0.5 | 150 | Validated |
Posaconazole | Antifungal | Generic | LC/MS/MS | 2 | 2000 | Validated |
Posaconazole | Antifungal | Generic | LC/MS/MS | 2 | 2000 | Validated |
Pralsetinib | Kinase inhibitors | Generic | LC/MS/MS | 2 | 2000 | Validated |
Pramipexole | Antiparkinsonian | Generic | LC/MS/MS | 0.02 | 4 | Validated |
Pravastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.4 | 200 | Validated |
Pravastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.3 | 200 | Validated |
Praziquantel | Anthelmintic | Generic | LC/MS/MS | 10 | 4000 | Validated |
Praziquantel | Anthelmintic | Generic | LC/MS/MS | 2 | 2000 | Validated |
Prazosin | Antihypertensive | Generic | LC/MS/MS | 0.2 | 60 | Validated |
Pregabalin | Anticonvulsant | Generic | LC/MS/MS | 30 | 15000 | Validated |
Pregabalin | Anticonvulsant | Generic | LC/MS/MS | 15 | 4000 | Validated |
Pregabalin | Anticonvulsant | Generic | LC/MS/MS | 15 | 4000 | Validated |
Pregabalin+ Gabapentin+ Carbamazepine+ Levetiracetam | Antiepileptic | Generic | LC/MS/MS | 30 100 10 60 |
6000 20000 2000 120000 |
Validated |
Primaquine | Antimalarial | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Primidone | Anticonvulsant | Generic | LC/MS/MS | 50 | 40000 | Validated |
Primidone | Anticonvulsant | Generic | LC/MS/MS | 10 | 3000 | Validated |
Propafenone+ 5-Hydroxy Propafenone | Antiarrhythmic | Generic | LC/MS/MS | 0.20 0.20 |
400 400 |
Validated |
Potassium | Hypokalaemia | Generic | LC/MS/MS | 20000 | 3000000 | Validated |
Prasugrel Metabolite R95913 | Platelet Inhibitor (Prasugrel) | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Prochlorperazine | Tranquilliser | Generic | LC/MS/MS | 0.002 | 0.6 | Validated |
Prochlorperazine | Tranquilliser | Generic | LC/MS/MS | 0.01 | 3 | Validated |
Procyclidine | Anticholinergic, Antiparkinsonian | Generic | LC/MS/MS | 1 | 300 | Validated |
Proguanil | Antimalarial | Generic | LC/MS/MS | 5 | 1000 | Validated |
Promazine | Phenothiazines | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Promethazine | Antihistaminic | Generic | LC/MS/MS | 0.2 | 60 | Validated |
Propofol | Sedative-hypnotic | Generic | LC/MS/MS | 5 | 5000 | Validated |
Propafenone + 5-Hydroxy metabolite | Anti-arrhythmic | Generic | LC/MS/MS | 5 2.50 |
1000 500 |
Validated |
Propranolol + 4-Hydroxy Propranolol(Free) | Antihypertensive | Generic | LC/MS/MS | 0.10 0.30 |
100 30 |
Validated |
2-Pyridyl Acetic Acid | Pyridines and derivatives | Generic | LC/MS/MS | 5 | 2500 | Validated |
Pyrazinamide | Antitubercular | Generic | LC/MS/MS | 200 | 60000 | Validated |
Pyridostigmine | Anticholinesterase | Generic | LC/MS/MS | 0.5 | 150 | Validated |
Pyridoxal | Vitamin B6 | Generic | LC/MS/MS | 0.3 | 200 | Validated |
Pyridoxal 5’-phosphate | Vitamin B6 | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Pyrimethamine | Antibacterial, Antimalarial | Generic | LC/MS/MS | 2 | 1000 | Validated |
Quetiapine | Antipsychotic | Generic | LC/MS/MS | 2 | 2000 | Validated |
Quetiapine | Antipsychotic | Generic | LC/MS/MS | 0.2 | 200 | Validated |
Quetiapine | Antipsychotic | Generic | LC/MS/MS | 1 | 600 | Validated |
Quinine | Antimalarial | Generic | LC/MS/MS | 40 | 8000 | Validated |
Quinidine | Antianginal | Generic | LC/MS/MS | 4 | 4000 | Validated |
Rabeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 3 | 2000 | Validated |
Rabeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 3 | 1000 | Validated |
Rabeprazole | Proton pump inhibitor | Generic | LC/MS/MS | 4 | 2000 | Validated |
Raltegravir | Antiviral | Generic | LC/MS/MS | 20 | 3000 | Validated |
Raltegravir | Antiviral | Generic | LC/MS/MS | 20 | 10000 | Validated |
Raltegravir | Antiviral | Generic | LC/MS/MS | 5 | 10000 | Validated |
Ramipril | Antihypertensive | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Ramipril+ Ramiprilat |
Antihypertensive | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Ranitidine | Antihistamine (H2 Antagonist) | Generic | LC/MS/MS | 5 | 1000 | Validated |
Ranitidine | Antihistamine | Generic | LC/MS/MS | 10 | 3000 | Validated |
Ranolazine | Antianginal | Generic | LC/MS/MS | 4 | 8000 | Validated |
Ranolazine | Antianginal | Generic | LC/MS/MS | 10 | 6000 | Validated |
Ranolazine | Antianginal | Generic | LC/MS/MS | 2 | 2000 | Validated |
Rasagiline | Parkinsons disease | Generic | LC/MS/MS | 0.02 | 10 | Validated |
Regorafenib | Kinase inhibitors | Generic | LC/MS/MS | 10 | 2500 | Validated |
Relugolix | Gonadotropin-releasing hormone (GnRH) receptor antagonists | Generic | LC/MS/MS | 0.5 | 400 | Validated |
Repaglinide | Antidiabetic | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Repaglinide + 3-Hydroxy Repaglinide | Antidiabetic | Generic | LC/MS/MS | 0.050 0.050 |
10 10 |
Validated |
Ribociclib Succinate | Kinase inhibitors | Generic | LC/MS/MS | 1 | 1200 | Validated |
Rifampicin | Antitubercular | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Rifapentine | Antimycobacterials | Generic | LC/MS/MS | 30 | 12000 | Validated |
Rifampicin + 25-Desacetyl Rifampicin |
Antitubercular | Generic | LC/MS/MS | 100 10 |
20000 2000 |
Validated |
Rifaximin | Antibiotic | Generic | LC/MS/MS | 0.025 | 10 | Validated |
Rifaximin | Antibiotic | Generic | LC/MS/MS | 0.009 | 12 | Validated |
Rilpivirin | Non-nucleoside Reverse Transcriptase Inhibitor | Generic | LC/MS/MS | 2 | 500 | Validated |
Riociguat | Soluble guanylate cyclase (sGC) stimulators | Generic | LC/MS/MS | 0.5 | 300 | Validated |
Ripretinib | Kinase inhibitors | Generic | LC/MS/MS | 2 | 600 | Validated |
Riluzole | Amyotrophic lateral sclerosis | Generic | LC/MS/MS | 1 | 500 | Validated |
Risperidone + 9-Hydroxy Risperidone |
Antipsychotic | Generic | LC/MS/MS | 0.20 0.20 |
100 100 |
Validated |
Ritonavir | Antiretroviral | Generic | LC/MS/MS | 2.5 | 1500 | Validated |
Rivoroxaban | Oral Anticoagulant | Generic | LC/MS/MS | 1 | 800 | Validated |
Rivaroxaban | Oral Anticoagulant | Generic | LC/MS/MS | 0.5 | 500 | Validated |
Rivaroxaban | Oral Anticoagulant | Generic | LC/MS/MS | 0.5 | 800 | Validated |
Rivastigmine | Alzheimer's&Parkinson's Disease | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Rivastigmine | Alzheimer's & Parkinson's Disease | Generic | LC/MS/MS | 0.03 | 30 | Validated |
Rizatriptan | Anti-migraine | Generic | LC/MS/MS | 0.1 | 100 | Validated |
Rizatriptan | Anti-Migraine | Generic | LC/MS/MS | 0.1 | 60 | Validated |
Roflumilast | Severe COPD associated with chronic bronchitis | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Roflumilast + Roflumilast N-Oxide | Severe COPD associated with chronic bronchitis | Generic | LC/MS/MS | 0.20 0.25 |
40 50 |
Validated |
Ropinirole | Antiparkinsonian | Generic | LC/MS/MS | 0.02 | 4 | Validated |
Ropinirole | Antiparkinsonian | Generic | LC/MS/MS | 0.02 | 4 | Validated |
Rosiglitazone + Metformin | Antidiabetic | Generic | LC/MS/MS | 6 40 |
1100 7600 |
Validated |
Rosiglitazone + N-Desmethyl Rosiglitazone | Antidiabetic | Generic | LC/MS/MS | 5. 2.50 |
1000 500 |
Validated |
Rosuvastatin + Dextromethorphan+Midazolam | Antihyperlipidemic + antitussives + Benzodiazepines | Generic | LC/MS/MS | 0.05 0.01 0.05 |
10 2 10 |
Validated |
Rosuvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.6 | 100 | Validated |
Rosuvastatin | Lowering Cholesterol | Generic | LC/MS/MS | 0.5 | 150 | Validated |
Rosuvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Rosuvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Rosuvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 1 | 2000 | Validated |
Rotigotine | Antiparkinsonian | Generic | LC/MS/MS | 0.002 | 1.2 | Validated |
Rufinamide | Anticonvulsant | Generic | LC/MS/MS | 30 | 9000 | Validated |
Ruxolitinib | Kinase inhibitors | Generic | LC/MS/MS | 1 | 500 | Validated |
Ruxolitinib | Kinase inhibitors | Generic | LC/MS/MS | 3 | 3000 | Validated |
Salbutamol | Ashtma | Generic | LC/MS/MS | 2 | 1000 | Validated |
Salmeterol | Asthma | Generic | LC/MS/MS | 0.001 | 0.5 | Validated |
Sacubitril + Valsartan | Antihypertensive | Generic | LC/MS/MS | 15 25 |
6000 10000 |
Validated |
Sacubitril + Sacubitrilat + Valsartan |
Antihypertensive | Generic | LC/MS/MS | 15 50 25 |
6000 20000 10000 |
Validated |
Scopolamine | Anticholinergic | Generic | LC/MS/MS | 0.005 | 0.5 | Validated |
Secnidazole | Antiamoebic | Generic | LC/MS/MS | 200 | 80000 | Validated |
Selpercatinib | Kinase inhibitors | Generic | LC/MS/MS | 10 | 4000 | Validated |
Selexipag & Its Metabolite | Antihypertensive | Generic | LC/MS/MS | 0.05 0.05 |
50 50 |
Validated |
Sertraline | Antidepressant | Generic | LC/MS/MS | 1.5 | 300 | Validated |
Sertraline | Antidepressant | Generic | LC/MS/MS | 0.2 | 80 | Validated |
Sertraline | antidepressants | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Sildenafil | Antihypertensive, Erectile dysfunction | Generic | LC/MS/MS | 8 | 1040 | Validated |
Sildenafil + Metabolite | Antihypertensive, Erectile dysfunction | Generic | LC/MS/MS | 2 | 1000 | Validated |
Sildenafil + Piperazine N-desmethyl Sildenafil | Antihypertensive, Erectile dysfunction | Generic | LC/MS/MS | 5 1 |
2000 400 |
Validated |
Sildenafil + N-desmethyl sildenafil | Antihypertensive, Erectile dysfunction |
Generic | LC/MS/MS | 1 0.20 |
500 100 |
Validated |
Sildenafil + N-desmethyl Sildenafil | Antihypertensive, Erectile dysfunction |
Generic | LC/MS/MS | 1 0.20 |
500 100 |
Validated |
Silodosin + Silodsoin Glucuronide | Benign prostatic hyperplasia | Generic | LC/MS/MS | 0.50 0.40 |
300 240 |
Validated |
Siimvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.04 | 20 | Validated |
Simvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.04 | 32 | Validated |
Simvastatin Acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.015 | 7.5 | Validated |
Simvastatin Acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.015 | 12 | Validated |
Simvastatin + β - hydroxy Acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Simvastatin + β - hydroxy Acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.25 | 32 | Validated |
Simvastatin + Simvastatin acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.200 0.200 |
100 100 |
Validated |
Simvastatin + Simvastatin Acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.50 0.50 |
200 200 |
Validated |
Simvastatin + Simvastatin Hydroxy Acid | Antihyperlipidemic | Generic | LC/MS/MS | 0.20 0.10 |
200 100 |
Validated |
Sirolimus | Immunosuppressant | Generic | LC/MS/MS | 0.4 | 40 | Validated |
Sirolimus (Sensitive) | Immunosuppressant | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Sirolimus | Immunosuppressants | Generic | LC/MS/MS | 0.1 | 40 | Validated |
Sirolimus | Immunosuppressant | Generic | LC/MS/MS | 0.05 | 15 | Validated |
Sitagliptin | Antihyperglycemic | Generic | LC/MS/MS | 2 | 800 | Validated |
Sitagliptin & Dapagliflozin | Antidiabetic | Generic | LC/MS/MS | 3.000 1.000 |
900 300 |
Validated |
Sitagliptin & Dapagliflozin | Antidiabetic | Generic | LC/MS/MS | 1 | 300 | Validated |
Sodium Phenyl Butyrate + Metabolite Phenyl acetate+ Metabolite Phenylacetylglutamine | For Urea cycle disorders | Generic | LC/MS/MS | 5 µg/mL 1 µg/mL 2 µg/mL |
750 µg/mL 750µg/mL 300 µg/mL |
Validated |
Sofosbuvir | Antiviral | Generic | LC/MS/MS | 5 | 2000 | Validated |
Sofosbuvir + Sofosbuvir GS331007 | Antiviral | Generic | LC/MS/MS | 5 10 |
1500 3000 |
Validated |
Solifenacin | Urinary antispasmodic | Generic | LC/MS/MS | 0.5 | 125 | Validated |
Solifenacin (Sensitive) | Antimuscarinic | Generic | LC/MS/MS | 0.2 | 130 | Validated |
Sorafenib | Anticancer | Generic | LC/MS/MS | 50 | 10000 | Validated |
Sorafenib | Anticancer | Generic | LC/MS/MS | 20 | 8000 | Validated |
Sotalol | Antiarrhythmic | Generic | LC/MS/MS | 10 | 3000 | Validated |
Spironolactone | Antihypertensive | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Sulfadiazine | Antibacterial | Generic | LC/MS/MS | 250 | 40000 | Validated |
Sulphamethoxazole + Trimethoprim | Antibacterial | Generic | LC/MS/MS | 0.50 0.025 |
100 5 |
Validated |
Sulfamethoxazole + Trimethoprim | Antibacterial | Generic | LC/MS/MS | 150 5 |
30000 1000 |
Validated |
Sumatripatan | Anti-migraine | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Sumatriptan | Selective serotonin receptor agonists | Generic | LC/MS/MS | 0.5 | 200 | Validated |
Sumatriptan | Selective serotonin receptor agonists | Generic | LC/MS/MS | 0.1 | 50 | Validated |
Sunitinib | Anticancer | Generic | LC/MS/MS | 0.25 | 100 | Validated |
Sunitinib | Anticancer | Generic | LC/MS/MS | 0.05 | 25 | Validated |
Sulfadoxine | Antibacterial | Generic | LC/MS/MS | 1000 | 400000 | Validated |
Tacrolimus | Immunosuppressant | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Tacrolimus | Immunosuppressant | Generic | LC/MS/MS | 0.25 | 75 | Validated |
Tacrolimus | Immunosuppressant | Generic | LC/MS/MS | 0.05 | 75 | Validated |
Tadalafil | Antihypertensive, Erectile dysfunction | Generic | LC/MS/MS | 2 | 800 | Validated |
Tamsulosin | Prostatic hyperplasia | Generic | LC/MS/MS | 0.05 | 30 | Validated |
Tamsulosin | α1a-selective alpha blocker | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Tamsulosin | Prostatic hyperplasia | Generic | LC/MS/MS | 0.05 | 60 | Validated |
Tapentadol | Analgesic | Generic | LC/MS/MS | 0.1 | 200 | Validated |
Telmisartan | Antihypertensive | Generic | LC/MS/MS | 3 | 1200 | Validated |
Telmisartan | Antihypertensive | Generic | LC/MS/MS | 5 | 1000 | Validated |
Telmisartan | Antihypertensive | Generic | LC/MS/MS | 2 | 500 | Validated |
Telmisartan + Amlodipine | Antihypertensive | Generic | LC/MS/MS | 2.50 0.075 |
500 15 |
Validated |
Temozolamide | Anticancer | Generic | LC/MS/MS | 100 | 20000 | Validated |
Temozolomide | Anticancer | Generic | LC/MS/MS | 100 | 20000 | Validated |
Tenofovir | Antiviral | Generic | LC/MS/MS | 5 | 1000 | Validated |
Tenofovir | Antiviral | Generic | LC/MS/MS | 5 | 1000 | Validated |
Tenofovir | Antiviral | Generic | LC/MS/MS | 0.4 | 50 | Validated |
Tenofovir + Emtricitabine + Lamivudine | Antiviral | Generic | LC/MS/MS | 4 15 20 |
800 3000 4000 |
Validated |
Tenofovir | Antiviral | Generic | LC/MS/MS | 5 | 1000 | Validated |
Tenofovir+ Emtricitabine | Antiviral | Generic | LC/MS/MS | 8 30 |
1600 6000 |
Validated |
Tenofovir + Emtricitabine + Rilpivirine | Antiritroviral | Generic | LC/MS/MS | 4 20 1 |
800 4000 200 |
Validated |
Tenofovir + Emtricitabine + Nevirapine | Antiritroviral | Generic | LC/MS/MS | 4 20 20 |
800 4000 4000 |
Validated |
Tenofovir Alafenamide | Antiviral | Generic | LC/MS/MS | 2 | 1000 | Validated |
Tenofovir Alafenamide + Lamivudine | Antiviral | Generic | LC/MS/MS | 2 20 |
500 5000 |
Validated |
Terazosin | Alpha-blockers | Generic | LC/MS/MS | 0.4 | 40 | Validated |
Terazosin | Alpha-blockers | Generic | LC/MS/MS | 0.4 | 400 | Validated |
Terbinafine | Antifungal | Generic | LC/MS/MS | 25 | 5000 | Validated |
Terbinafine | Antifungal | Generic | LC/MS/MS | 10 | 3000 | Validated |
Teriflunomide | Multiple sclerosis | Generic | LC/MS/MS | 10 | 4000 | Validated |
Tetrabenazine | Huntington's disease | Generic | LC/MS/MS | 0.01 | 2 | Validated |
Tetracycline | Antibiotic | Generic | LC/MS/MS | 20 | 8000 | Validated |
Theophylline | Xanthines | Generic | LC/MS/MS | 50 | 40000 | Validated |
Thiamine | Vtamin B1 | Generic | LC/MS/MS | 0.2 | 30 | Validated |
Tiagabine | Anticonvulsant | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Ticagrelor | Platelet aggregation inhibitor | Generic | LC/MS/MS | 2.5 | 1200 | Validated |
Ticagrelor | Platelet aggregation inhibitor | Generic | LC/MS/MS | 5 | 2500 | Validated |
Ticagrelor+ Desethoxyhydroxy Ticagrelor | Platelet aggregation inhibitor | Generic | LC/MS/MS | 2.50 1 |
1250 500 |
Validated |
Ticagrelor and its metabolite | Platelet aggregation inhibitor | Generic | LC/MS/MS | 5 2 |
3500 1400 |
Validated |
Tinidazole | Antiprotozoal | Generic | LC/MS/MS | 50 | 30000 | Validated |
Tivozanib | Kinase inhibitors | Generic | LC/MS/MS | 0.2 | 50 | Validated |
Tizanidine | Muscle Relexant | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Tizanidine | Muscle Relexant | Generic | LC/MS/MS | 0.075 | 20 | Validated |
Tizanidine | Muscle Relexant | Generic | LC/MS/MS | 0.01 | 10 | Validated |
Tizoxanide | Antiparasitic | Generic | LC/MS/MS | 50 | 25000 | Validated |
Tofacitinib | Rheumatoid arthritis | Generic | LC/MS/MS | 0.2 | 100 | Validated |
Tofacitinib | Rheumatoid arthritis | Generic | LC/MS/MS | 0.2 | 200 | Validated |
Tolbutamide | Antidiabetic | Generic | LC/MS/MS | 500 | 100000 | Validated |
Tolcapone + 3-O-Methyltolcapone | Reversible inhibitor of catechol-O-methyltransferase (COMT) | Generic | LC/MS/MS | 40 2 |
8000 400 |
Validated |
Tolterodine | Urinary Iincontinence | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Tolterodine + 5-Hydroxy Methyl Tolterodine | Antimuscarinic | Generic | LC/MS/MS | 0.025 | 10 | Validated |
Tolterodine+ 5-Hydroxymethyl Tolterodine | Antimuscarinic | Generic | LC/MS/MS | 0.025 0.025 |
10 10 |
Validated |
Tolterodine + 5-Hydroxymethyl Tolterodine | Urinary Iincontinence | Generic | LC/MS/MS | 0.10 0.10 |
10 10 |
Validated |
Tolvaptan | Vasopressin antagonists | Generic | LC/MS/MS | 4 | 1600 | Validated |
Tolvaptan | Vasopressin antagonists | Generic | LC/MS/MS | 0.4 | 250 | Validated |
Tolvaptan | Vasopressin antagonists | Generic | LC/MS/MS | 4 | 2400 | Validated |
Topiramate | Anticonvulsant | Generic | LC/MS/MS | 18 | 5000 | Validated |
Topiramate | Anticonvulsant | Generic | LC/MS/MS | 5 | 5000 | Validated |
Topiramate | Anticonvulsant | Generic | LC/MS/MS | 5 | 5000 | Validated |
Topiramate | Anticonvulsant | Generic | LC/MS/MS | 2 | 1000 | Validated |
Torsemide | Antihypertensive | Generic | LC/MS/MS | 20 | 6000 | Validated |
Torsemide | Diuretic, Antihypertensive | Generic | LC/MS/MS | 25 | 12000 | Validated |
Torsemide | Antihypertensive | Generic | LC/MS/MS | 100 | 25000 | Validated |
Total Iron | Iron Defficiency Anaemia | Generic | LC/MS/MS | 500 | 60000 | Validated |
Total Iron (For FCM) | Iron Defficiency Anaemia | Generic | LC/MS/MS | 400 | 800000 | Validated |
Total Topotecan | Topoisomerase | Generic | LC/MS/MS | 0.25 | 100 | Validated |
Tramadol hydrochloride | Analgesic | Generic | LC/MS/MS | 3 | 750 | Validated |
Trametinib | Anticancer | Generic | LC/MS/MS | 0.25 | 250 | Validated |
Tranexamic Acid | Antifibrinolytics | Generic | LC/MS/MS | 100 | 25000 | Validated |
Transferrin Bound Iron (for FCM) | Iron Defficiency Anaemia | Generic | ICP OES | 400 | 16000 | Validated |
Transferrin Bound Iron | Iron Defficiency Anaemia | Generic | ICP OES | 500 | 16000 | Validated |
Transerrin Bound Iron | For Estimation of transferrin bound Iron after Ferrmoxytol and Ferric carboxy maltose therapy | Generic | ICP OES | 500 | 20000 | Validated |
Tranylcypromine | Antidepressant and Anxiolytic | Generic | LC/MS/MS | 0.3 | 150 | Validated |
Tranylcypromine | Antidepressant and Anxiolytic | Generic | LC/MS/MS | 0.3 | 120 | Validated |
Trazodone | Antidepressant | Generic | LC/MS/MS | 10 | 3000 | Validated |
Triamcinolone acetonide | Glucocorticoid | Generic | LC/MS/MS | 0.02 | 6 | Validated |
Triamcinolone Acetonide | Glucocorticoid | Generic | LC/MS/MS | 0.005 | 2 | Validated |
Trifluoperazine | Antipsychotic | Generic | LC/MS/MS | 0.025 | 8 | Validated |
Trifluoperazine | Antipsychotics | Generic | LC/MS/MS | 0.005 | 5 | Validated |
Trimetazidine | Antianginal | Generic | LC/MS/MS | 1 | 202 | Validated |
Trimetazidine | Antianginal | Generic | LC/MS/MS | 1 | 500 | Validated |
1,3,5-Trimethoxy Benzene | Antispasmodic | Generic | LC/MS/MS | 0.25 | 70 | Validated |
Trimethyl Phloroglucinol | Antispasmodic | Generic | LC/MS/MS | 10 | 2500 | Validated |
Trospium | Overactive bladder | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Trospium | Overactive bladder | Generic | LC/MS/MS | 0.02 | 10 | Validated |
Trospium | Overactive bladder | Generic | LC/MS/MS | 0.02 | 20 | Validated |
Trospium | Overactive bladder | Generic | LC/MS/MS | 0.01 | 10 | Validated |
Ubenimex | Anticancer | Generic | LC/MS/MS | 15 | 6000 | Validated |
Ulipristal Acetate | Contraceptive | Generic | LC/MS/MS | 0.2 | 160 | Validated |
Upadacitinib | Janus kinase (JAK) inhibitor | Generic | LC/MS/MS | 0.4 | 120 | Validated |
Upadacitinib | Janus kinase (JAK) inhibitor | Generic | LC/MS/MS | 0.5 | 300 | Validated |
Valacyclovir + Acyclovir |
Antiviral | Generic | LC/MS/MS | 5 50 |
1000 10000 |
Validated |
Valganciclovir + Ganciclovir | Antiviral | Generic | LC/MS/MS | 2 20 |
1000 10000 |
Validated |
Valganciclovir + Ganciclovir | Antiviral | Generic | LC/MS/MS | 5 80 |
1250 20000 |
Validated |
Valproic acid | Anticonvulsant | Generic | LC/MS/MS | 400 | 40000 | Validated |
Valproic Acid | Anticonvulsant | Generic | LC/MS/MS | 1000 | 150000 | Validated |
Valproic acid | Anticonvulsant | Generic | LC/MS/MS | 1000 | 100000 | Validated |
Valproic acid | Anticonvulsant | Generic | LC/MS/MS | 500 | 100000 | Validated |
Valsartan | Antihypertensive | Generic | LC/MS/MS | 5 | 5000 | Validated |
Valsartan | Antihypertensive | Generic | LC/MS/MS | 20 | 12000 | Validated |
Valsartan + Hydrochlorothiazide | Angiotension II Receptor Antagonist Diuretic | Generic | LC/MS/MS | 40 1 |
12000 300 |
Validated |
Valsartan | Antihypertensive | Generic | LC/MS/MS | 40 | 18000 | Validated |
Varenicline | Nicotine Addiction | Generic | LC/MS/MS | 0.1 | 20 | Validated |
Varenicline | Chronic lymphocytic leukemia | Generic | LC/MS/MS | 10 | 3000 | Validated |
Venetoclax | Chronic lymphocytic leukemia | Generic | LC/MS/MS | 2 | 2000 | Validated |
Venlafaxine + O - Desmethyl Venlafaxine |
Antidepressant | Generic | LC/MS/MS | 2 3 |
500 750 |
Validated |
Venlafexine (Sensitive) + O - Desmethyl Venlafaxine |
Antidepressant | Generic | LC/MS/MS | 0.25 0.50 |
100 200 |
Validated |
Verapamil + Norverapamil |
Antihypertensive | Generic | LC/MS/MS | 2 2 |
500 500 |
Validated |
Vericiguat | Soluble guanylate cyclase (sGC) stimulators | Generic | LC/MS/MS | 1 | 600 | Validated |
Vertaric acid | Antihypertensive and Antioxidant | Generic | LC/MS/MS | 100 | 20000 | Validated |
Vildagliptin | Antidiabetic | Generic | LC/MS/MS | 2 | 800 | Validated |
Vildagliptin | Antidiabetic | Generic | LC/MS/MS | 3 | 1500 | Validated |
Vilazodone | Antidepressant | Generic | LC/MS/MS | 0.3 | 60 | Validated |
Vilazodone | Antidepressant | Generic | LC/MS/MS | 0.4 | 250 | Validated |
Voclosporin | Calcineurin inhibitors | Generic | LC/MS/MS | 0.5 | 120 | Validated |
Vonoprazan | Potassium-competitive acid blockers (PCAB) | Generic | LC/MS/MS | 0.2 | 40 | Validated |
Voriconazole(Sensitive) | Antifungal | Generic | LC/MS/MS | 30 | 9000 | Validated |
Voriconazole (Sensitive) | Antifungal | Generic | LC/MS/MS | 25 | 5000 | Validated |
Voriconazole | Antifungal | Generic | LC/MS/MS | 5 | 1000 | Validated |
Vortioxetine | Antidepressant | Generic | LC/MS/MS | 0.05 | 20 | Validated |
Warfarin | Anticoagulant | Generic | LC/MS/MS | 1 | 500 | Validated |
Warfarin | Anticoagulant | Generic | LC/MS/MS | 10 | 5000 | Validated |
Zanubrutinib | Kinase inhibitors | Generic | LC/MS/MS | 2 | 800 | Validated |
Zidovudine | Antiviral | Generic | LC/MS/MS | 75 | 6000 | Validated |
Zidovudine (Sensitive) | Antiviral | Generic | LC/MS/MS | 20 | 4000 | Validated |
Zinc (Zinc Acetate) | Inhibit the absorption of copper in Wilson's disease | Generic | LC/MS/MS | 300 | 25000 | Validated |
Zolpidem | Insomnia | Generic | LC/MS/MS | 0.5 | 300 | Validated |
Zolpidem | Insomnia | Generic | LC/MS/MS | 1 | 600 | Validated |
Zonisamide | Antiepileptic | Generic | LC/MS/MS | 10 | 3000 | Validated |
Zonisamide+ Topiramate + Oxcarbazepine + Phenytoin | Antiepileptic | Generic | LC/MS/MS | 300 100 10 60 |
6000 20000 2000 12000 |
Validated |
Zopiclone | Hypnotic | Generic | LC/MS/MS | 0.5 | 200 | Validated |
4-Plex Amino acid (O-Acetyl-L-Carnitine, L-Carnitine, Creatine and L-Citrulline). | Amino acids | Generic | LC/MS/MS | 40 80 |
8000 16000 |
Validated |
6-Mercaptopurine | Purine antagonists. | Generic | LC/MS/MS | 1 | 400 | Validated |
Acitretin + 13 - Cis Acitretin | Psoriasis | Generic | LC/MS/MS | 2 | 500 | Validated |
Amino Acids (20 amino acids) | Amino Acids | Generic | LC/MS/MS | 100 150 500 1000 2000 |
4000 6000 20000 40000 80000 |
Validated |
Amphotericin B (Free) | Antifungal | Generic | LC/MS/MS | 5 | 2500 | Validated |
Amphotericin B (Liposomal ) | Antifungal | Generic | LC/MS/MS | 100 | 40000 | Validated |
Aspirin | anti-inflammatory | Generic | LC/MS/MS | 5 | 3000 | Validated |
Aspirin + Salicylic acid (Sensitive) |
Analgesic | Generic | LC/MS/MS | 2 150 |
1200 10000 |
Validated |
Atorvastatin + 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin+ Glimpride+ Glimpride M1 Metabolite |
Antihyperlipidemic Antidiabetic |
Generic | LC/MS/MS | 0.10 0.10 0.05 0.50 0.50 |
40 40 20 200 200 |
Validated |
5-Azacitidine | Anticancer | Generic | LC/MS/MS | 10 | 2500 | Validated |
Bupropion + Hydroxy Bupropion+ Erythro Bupropion + Threo Bupropion |
Antidepressant and Smoking cessation | Generic | LC/MS/MS | 3 10 3 5 |
900 3000 900 1500 |
Validated |
Bupropion + Hydroxy Bupropion + Erythro Bupropion + Threo Bupropion |
Antidepressant | Generic | LC/MS/MS | 1 3 0.80 2.50 |
300 900 240 750 |
Validated |
Bupropion + Hydroxy Bupropion+ Erythrohydro Bupropion + Threohydro Bupropion |
Antidepressant | Generic | LC/MS/MS | 0.60 4 0.30 1.20 |
300 2000 150 600 |
Validated |
Budesonide | Glucocorticoid | Generic | LC/MS/MS | 0.003 | 8 | Validated |
Cabergoline | Dopamine receptor agonist | Generic | LC/MS/MS | 0.500pg/mL | 100pg/mL | Validated |
Coproporphyrine-I | Porphyrins | Generic | LC/MS/MS | 0.05 | 5 | Validated |
Calcitriol | vitamin D analogs | Generic | LC/MS/MS | 0.02 | 0.6 | Validated |
Caffine | Stimulant | Generic | LC/MS/MS | 20 | 5000 | Validated |
Dabigatran(Total) | Thrombin Inhibitor | Generic | LC/MS/MS | 1 | 400 | Validated |
Digoxin | Digitalis glycosides | Generic | LC/MS/MS | 0.02 | 4 | Validated |
Disulfiram | For Chronic Alcoholism | Generic | LC/MS/MS | 25 | 5000 | Validated |
Docetaxel(Free) | Anticancer | Generic | LC/MS/MS | 1 | 600 | Validated |
Doxorubicin Metabolite (Doxorubicinol) | Anticancer | Generic | LC/MS/MS | 0.25 | 20 | Validated |
Doxorubicin(Free) | Anticancer | Generic | LC/MS/MS | 50 | 5000 | Validated |
Doxorubicin(Liposomal) | Anticancer | Generic | LC/MS/MS | 250 | 50000 | Validated |
Doxorubicin (Total) | Anticancer | Generic | LC/MS/MS | 250 | 50000 | Validated |
Doxorubicin (Free) | Anticancer | Generic | LC/MS/MS | 10 | 5000 | Validated |
Doxorubicin (Liposomal) | Anticancer | Generic | LC/MS/MS | 150 | 60000 | Validated |
Doxorubicin (Free ) | Anticancer | Generic | LC/MS/MS | 10 | 2000 | Validated |
Doxorubicin (Liposomal) | Anticancer | Generic | LC/MS/MS | 150 | 60000 | Validated |
Ergocalciferol | Vitamin D2 | Generic | LC/MS/MS | 0.1 | 100 | Validated |
Estrone Unconjugated +Estradiol Unconjugated + Norethindrone | Oestrogen Oestrogen Progestogen | Generic | LC/MS/MS | 0.003 0.001 0.100 |
0.400 0.133 13.3 |
Validated |
Estrone (Total) | Oestrogen | Generic | LC/MS/MS | 0.05 | 50 | Validated |
Ethinyl Estradiol(Sensitive) + Levonorgestrel | Oestrogen Progestogen |
Generic | LC/MS/MS | 0.002 0.100 |
0.250 25 |
Validated |
Ethinyl Estradiol and Drospirenone | Oestrogen Progestogen | Generic | LC/MS/MS | 0.0015 0.500 |
0.225 75 |
Validated |
Levonorgestrel & Ethinyl Estradiol | Oestrogen Progestogen |
Generic | LC/MS/MS | 0.100 0.004 |
20 0.800 |
Validated |
Equilin Total + 8,9-dehydroestrone Total | Oestrogen | Generic | LC/MS/MS | 0.050 0.025 |
8 4 |
Validated |
Estrone Total | Oestrogen | Generic | LC/MS/MS | 0.05 | 15 | Validated |
Estrone Uncojugated + Equilin Unconjugated + 8,9 Dehydroestrone Unconjugated | Oestrogen | Generic | LC/MS/MS | 0.0030 0.0045 0.0045 |
0.400 0.600 0.600 |
Validated |
Estrone (Unconjugated) +Estradiol (Unconjugated) | Oestrogen | Generic | LC/MS/MS | 0.003 0.001 |
0.48 0.16 |
Validated |
Fesoterodine +5-OH Methyl Tolterodine | Urinary Iincontinence | Generic | LC/MS/MS | 0.01 0.02 |
7.5 15 |
Validated |
Fingolimod + Fingolimod Phosphate | Multiple sclerosis | Generic | LC/MS/MS | 0.04 0.04 |
5 5 |
Validated |
Fingolimod + Fingolimod phosphate | Multiple sclerosis | Generic | LC/MS/MS | 0.010 0.010 |
5 5 |
Validated |
Fluphenazine | Antipsychotic | Generic | LC/MS/MS | 0.003 | 2.1 | Validated |
(+)-3R 5S Fluvastatin + 3S 5R Fluvastatin | Antihyperlipidemic | Generic | LC/MS/MS | 0.60 0.60 |
300 300 |
Validated |
Fluticasone Propionate | Corticosteroid, Asthma | Generic | LC/MS/MS | 0.002 | 500 | Validated |
Fluticasone Propionate | Corticosteroid, Asthma | Generic | LC/MS/MS | 0.0008 | 0.5 | Validated |
Fluticsone Furoate + Vilanterol | Long-acting beta agonists | Generic | LC/MS/MS | 0.5pg/mL 1pg/mL |
125pg/mL 500pg/mL |
Validated |
Formoterol | Long-acting beta agonists | Generic | LC/MS/MS | 0.0004 | 0.1 | Validated |
Formoterol | Asthma | Generic | LC/MS/MS | 0.0004 | 0.2 | Validated |
Formoterol | Long-acting beta agonists | Generic | LC/MS/MS | 0.0002 | 0.1 | Validated |
Free Amphotericin | Antifungal | Generic | LC/MS/MS | 15 | 5000 | Validated |
Glycopyrronium | Anticholinergics | Generic | LC/MS/MS | 0.002 | 1.2 | Validated |
Indacaterol | Long-acting beta agonists | Generic | LC/MS/MS | 0.002 | 0.7 | Validated |
Isosorbide Dinitrate + Isosorbide 2-mono nitrate + Isosorbide 5-mono nitrate | Angina Pectoris, Congestive Heart Failure | Generic | LC/MS/MS | 0.40 2 2 |
100 500 500 |
Validated |
Ivermectin | Anthelmintics | Generic | LC/MS/MS | 0.01 | 1.2 | Validated |
Ivermectin B1a and Ivermectin B1b | Anthelmintics | Generic | LC/MS/MS | 0.150 0.0075 |
150 2.250 |
Validated |
Liposomal Amphotericin | Antifungal | Generic | LC/MS/MS | 65 | 65000 | Validated |
Melatonin | Acetamides | Generic | LC/MS/MS | 0.005 | 5 | Validated |
Mesalamine& N-Acetyl Mesalamine | Anti-inflammatory | Generic | LC/MS/MS | 5.0 10.0 |
5000 10000 |
Validated |
Mesna | Cytoprotectants | Generic | LC/MS/MS | 40 | 5000 | Validated |
Progesterone | Progestogen | Generic | LC/MS/MS | 0.02 | 40 | Validated |
R & S Oxybutynin | Anticholinergic | Generic | LC/MS/MS | 0.02 0.04 |
10 20 |
Validated |
13-cis-Retinoic Acid+4-Keto 13-cis-Retinoic Acid | Vitamin A | Generic | LC/MS/MS | 5 10 |
1000 2000 |
Validated |
2-Hydroxy Oleic Acid | Synthetic derivative of Oleic Acid | Generic | LC/MS/MS | 25 | 25000 | Validated |
R-Ibuprofen+ S-Ibuprofen |
NSAID | Generic | LC/MS/MS | 1000 | 32000 | Validated |
Insulin Glargine + Metabolite M1 + Metabolite M2 | Antidiabetic | Generic | LC/MS/MS | 0.200 0.160 0.166 |
5 4 4.150 |
Validated |
R-Ibuprofen + S-Ibuprofen | NSAID | Generic | LC/MS/MS | 200 200 |
70000 70000 |
Validated |
Isoniazide + Rifampicin + 25 -Desacetyl Rifampicin+Ethambutol +Pyrazinamide | Antitubercular | Generic | LC/MS/MS | 60 15 25 15 200 |
6000 1500 2500 1500 20000 |
Validated |
R-Ketoprofen +S-Ketoprofen | NSAID | Generic | LC/MS/MS | 25 25 |
15000 15000 |
Validated |
R-Lercanidipine +S-Lercanidipine | Antihypertensive | Generic | LC/MS/MS | 0.025 0.025 |
20 20 |
Validated |
Levodapa & 3-O-Methyldopa | central nervous system agents | Generic | LC/MS/MS | 25 10 |
5000 5000 |
Validated |
Lurasidone Metabolite 14283 | Antipsychotic | Generic | LC/MS/MS | 1 | 1000 | Validated |
Medroxy Progesterone acetate | Antineoplastics | Generic | LC/MS/MS | 0.025 | 10 | Validated |
Metformin+ Pioglitazone+ Hydroxy Pioglitazone | Antidiabetic | Generic | LC/MS/MS | 10 | 2400 | Validated |
Mycophenolate Mofetil+ Mycophenolic acid | Immunosuppressant | Generic | LC/MS/MS | 0.02 40 |
20 40000 |
Validated |
R-Metoprolol+ S-Metoprolol | Antihypertensive | Generic | LC/MS/MS | 2 | 500 | Validated |
S-Methyl N, N- Diethyl dithiocarbamate (Disulfiram Secondary Metabolite ) | For Chronic Alcoholism (Disulfiram) | Generic | LC/MS/MS | 5 | 1000 | Validated |
RSSS -Nebivolol+ SRRR-Nebivolol | Antihypertensive | Generic | LC/MS/MS | 0.020 0.020 |
6 6 |
Validated |
N-Acetyl-L-Cysteine | Chronic bronchopulmonary disease | Generic | LC/MS/MS | 20 | 4000 | Validated |
Niacin+ Nicotinuric Acid(Metabolite) | Vitamin | Generic | LC/MS/MS | 5 15 |
1000 3000 |
Validated |
Nitroglycerin +1, 2-Dinitroglycerin +1, 3-Dinitroglycerin | Vasodilator | Generic | LC/MS/MS | 0.020 0.050 0.050 |
2 5 5 |
Validated |
Nitroglycerin+ 1,2-Dinitroglycerin+ 1,3-Dinitroglycerin | Vasodilator | Generic | LC/MS/MS | 0.010 0.020 0.010 |
5 10 5 |
Validated |
Paclitaxel (Free, Unbound) | Anticancer | Generic | LC/MS/MS | 1 | 1500 | Validated |
Paclitaxel (Free) | Anticancer | Generic | LC/MS/MS | 10 | 2000 | Validated |
Penicillamine | Chelating Agent | Generic | LC/MS/MS | 15 | 4000 | Validated |
Phenindione | Anticoagulant/Vitamin K antagonist | Generic | LC/MS/MS | 50 | 20000 | Validated |
Prednisolone | Corticosteroid | Generic | LC/MS/MS | 2 | 1000 | Validated |
Prednisolone | Corticosteroid | Generic | LC/MS/MS | 0.3 | 70 | Validated |
Propranolol (Total)+ 4- Hydroxy Propranolol (Total) | Antihypertensive | Generic | LC/MS/MS | 1 0.500 |
500 250 |
Validated |
Propranolol & 4- Hydroxy Propranolol | Antihypertensive | Generic | LC/MS/MS | 1 0.50 |
500 250 |
Validated |
cis & trans-Phytonadione | Vitamin K | Generic | LC/MS/MS | 0.100 0.100 |
150 150 |
Validated |
trans Phytonadione & cis Phytonadione | Vitamin K | Generic | LC/MS/MS | 0.200 0.100 |
400 200 |
Validated |
R-Praziquantel+ S-Praziquantel | Anthelmintic | Generic | LC/MS/MS | 2 2 |
2000 2000 |
Validated |
Progesterone | Progestogen | Generic | LC/MS/MS | 0.025 | 25 | Validated |
Propranolol Total +4-OH Propranolol Total | Beta–adrenoceptor Blocking Agent | Generic | LC/MS/MS | 2 | 500 | Validated |
R-(+) -trans -tranylcypromine+ S-(-) -trans-tranylcypromine | Antidepressant and Anxiolytic | Generic | LC/MS/MS | 0.100 0.200 |
40 80 |
Validated |
Rivastigmine(Sensitive) | Alzheimer's & Parkinson's Disease | Generic | LC/MS/MS | 0.05 | 20 | Validated |
R-Warfarin+ S-Warfarin | Anticoagulant | Generic | LC/MS/MS | 1 1 |
1000 1000 |
Validated |
S-Baclofen & R-Baclofen | Muscle relaxant and antispastic | Generic | LC/MS/MS | 0.5 | 250 | Validated |
Trientine+ N1 -Acetyl triethylenetetramine | Chelating agent | Generic | LC/MS/MS | 6 10 |
1500 2500 |
Validated |
Trientine+ N1 -Acetyl triethylenetetramine + N1,N10 -Diacetyl triethylenetetramine | Chelating agent | Generic | LC/MS/MS | 10 10 3 |
2000 2000 600 |
Validated |
Tiopronin | Cystinuria | Generic | LC/MS/MS | 20 | 12000 | Validated |
Tiotropium | Anticholinergic | Generic | LC/MS/MS | 0.20 pg/mL | 100 pg/mL | Validated |
Topotecan Lactone | Topoisomerase | Generic | LC/MS/MS | 0.5 | 100 | Validated |
Total Amphotericin | Antifungal | Generic | LC/MS/MS | 100 | 40000 | Validated |
Total estrone | Oestrogen | Generic | LC/MS/MS | 0.05 | 50 | Validated |
Total Iron | Iron Defficiency Anaemia | Generic | LC/MS/MS | 400 | 800000 | Validated |
Transferrin Bound Iron | Iron Defficiency Anaemia | Generic | LC/MS/MS | 400 | 50000 | Validated |
Umeclidinium | Long-acting beta agonists | Generic | LC/MS/MS | 0.0015 | 0.75 | Validated |
Unbound Paclitaxel | Anticancer | Generic | LC/MS/MS | 2.5 | 1500 | Validated |
Uncojugated Estrone and Eqiline | Oestrogen | Generic | LC/MS/MS | 0.002 0.001 |
0.300 0.150 |
Validated |
Uridine and LDHO | pyrimidine analogs | Generic | LC/MS/MS | 30 3 |
30000 3000 |
Validated |
VIN-NCE-001 PL-1 | NCE | LC/MS/MS | 0.5 | 500 | Validated | |
VIN-NCE-001 UR-1 | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-002 PL | NCE | LC/MS/MS | 10 | 2000 | Validated | |
VIN-NCE-003 PL | NCE | LC/MS/MS | 20 | 5000 | Validated | |
VIN-NCE-004 PL | NCE | LC/MS/MS | 0.02 | 10 | Validated | |
VIN-NCE-005 PL | NCE | LC/MS/MS | 0.5 | 100 | Validated | |
VIN-NCE-006 PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-007 PL | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-008 PL | NCE | LC/MS/MS | 0.1 | 100 | Validated | |
VIN-NCE-008 UR | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-009 PL | NCE | LC/MS/MS | 0.1 | 100 | Validated | |
VIN-NCE-009 UR | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-010 PL | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-011 PL | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-012 PL | NCE | LC/MS/MS | 0.5 | 500 | Validated | |
VIN-NCE-014 PL | NCE | LC/MS/MS | 25 | 1000 | Validated | |
VIN-NCE-013 PL | NCE | LC/MS/MS | 0.5 | 500 | Validated | |
VIN-NCE-015 PL | NCE | LC/MS/MS | 1 | 500 | Validated | |
VIN-NCE-016 PL | NCE | LC/MS/MS | 0.1 | 100 | Validated | |
VIN-NCE-017 BL | NCE | LC/MS/MS | 0.5 | 100 | Validated | |
VIN-NCE-018 BL | NCE | LC/MS/MS | 3 | 1200 | Validated | |
VIN-NCE-019 PL | NCE | LC/MS/MS | 10 | 250 | Validated | |
VIN-NCE-020 PL | NCE | LC/MS/MS | 1 | 25 | Validated | |
VIN-NCE-021 PL | NCE | LC/MS/MS | 0.03 | 100 | Validated | |
VIN-NCE-022 SK | NCE | LC/MS/MS | 12 | 9000 | Validated | |
VIN-NCE-023 PL | NCE | LC/MS/MS | 3 | 2400 | Validated | |
VIN-NCE-024 PL | NCE | LC/MS/MS | 0.5 | 1000 | Validated | |
VIN-NCE-025 UR | NCE | LC/MS/MS | 0.5 | 1000 | Validated | |
VIN-NCE-026 PL | NCE | LC/MS/MS | 0.3 | 200 | Validated | |
VIN-NCE-027 PL | NCE | LC/MS/MS | 2 | 1000 | Validated | |
VIN-NCE-028 PL | NCE | LC/MS/MS | 5 | 3000 | Validated | |
VIN-NCE-029 PL | NCE | LC/MS/MS | 2 | 2500 | Validated | |
VIN-NCE-030 TI | NCE | LC/MS/MS | 12 | 9000 | Validated | |
VIN-NCE-022 CT | NCE | LC/MS/MS | 12 | 9000 | Validated | |
VIN-NCE-031 PL | NCE | LC/MS/MS | 0.5 | 5000 | Validated | |
VIN-NCE-032 PL | NCE | LC/MS/MS | 0.05 | 50 | Validated | |
VIN-NCE-034 PL | NCE | LC/MS/MS | 0.005 | 5.5 | Validated | |
VIN-NCE-038 UR | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-037 UR | NCE | LC/MS/MS | 10 | 10000 | Validated | |
VIN-NCE-035 PL | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-041 PL | NCE | LC/MS/MS | 1 | 2000 | Validated | |
VIN-NCE-039PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-043 PL | NCE | LC/MS/MS | 2 | 1000 | Validated | |
VIN-NCE-037UR | NCE | LC/MS/MS | 10 | 10000 | Validated | |
VIN-NCE-042PL | NCE | LC/MS/MS | 0.02 | 10 | Validated | |
VIN-NCE-044PL (Drug + Metabolite) | NCE | LC/MS/MS | 1 1 |
1000 1000 |
Validated | |
VIN-NCE-040PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-045PL | NCE | LC/MS/MS | 0.5 | 2000 | Validated | |
VIN-NCE-046PL (Drug + Metabolite) | NCE | LC/MS/MS | 5 1 |
5000 1000 |
Validated | |
VIN-NCE-047UR | NCE | LC/MS/MS | 1 | 2000 | Validated | |
VIN-NCE-048PL | NCE | LC/MS/MS | 1 | 5000 | Validated | |
VIN-NCE-049PL (Drug + Metabolite) | NCE | LC/MS/MS | 0.005 0.20 |
5 |
Validated | |
VIN-NCE-050PL | NCE | LC/MS/MS | 1 | 5000 | Validated | |
VIN-NCE-51PL | NCE | LC/MS/MS | 0.50 0.50 |
1000 1000 |
Validated | |
VIN-NCE-52PL | NCE | LC/MS/MS | 0.02 | 50 | Validated | |
VIN-NCE-53UR | NCE | LC/MS/MS | 10 | 50 | Validated | |
VIN-NCE-54PL | NCE | LC/MS/MS | 50 | 20000 | Validated | |
VIN-NCE-55PL | NCE | LC/MS/MS | 300µg/mL | 5000µg/mL | Validated | |
VIN-NCE-56PL | NCE | LC/MS/MS | 0.02 | 20 | Validated | |
VIN-NCE-57PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-58PL | NCE | LC/MS/MS | 1 | 10000 | Validated | |
VIN-NCE-59PL | NCE | LC/MS/MS | 2 | 1000 | Validated | |
VIN-NCE-60PL | NCE | LC/MS/MS | 2 | 2500 | Validated | |
VIN-NCE-61PL | NCE | LC/MS/MS | 0.5 | 1500 | Validated | |
VIN-NCE-62UR | NCE | LC/MS/MS | 2 | 4000 | Validated | |
VIN-NCE-63PL | NCE | LC/MS/MS | 0.01 | 20 | Validated | |
VIN-NCE-64PL | NCE | LC/MS/MS | 2 | 1000 | Validated | |
VIN-NCE-65PL | NCE | LC/MS/MS | 1 5 10 5 |
2000 10000 20000 4000 |
Validated | |
VIN-NCE-66PL | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-67PL | NCE | LC/MS/MS | 1 | 2000 | Validated | |
VIN-NCE-68PL | NCE | LC/MS/MS | 1 | 6000 | Validated | |
VIN-NCE-69PL | NCE | LC/MS/MS | 0.04 0.040 |
80 80 |
Validated | |
VIN-NCE-70UR | NCE | LC/MS/MS | 2 | 1000 | Validated | |
VIN-NCE-71PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-72PL | NCE | LC/MS/MS | 0.2 | 400 | Validated | |
VIN-NCE-73UR | NCE | LC/MS/MS | 0.1 | 500 | Validated | |
VIN-NCE-74UR | NCE | LC/MS/MS | 5 | 5000 | Validated | |
VIN-NCE-75PL | NCE | LC/MS/MS | 0.2 | 600 | Validated | |
VIN-NCE-76PL | NCE | LC/MS/MS | 0.01 | 50 | Validated | |
VIN-NCE-77PL | NCE | LC/MS/MS | 5 | 40000 | Validated | |
VIN-NCE-78PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-79UR | NCE | LC/MS/MS | 0.01 | 50 | Validated | |
VIN-NCE-80PL | NCE | LC/MS/MS | 1 | 5000 | Validated | |
VIN-NCE-81PL | NCE | LC/MS/MS | 1 | 500 | Validated | |
VIN-NCE-82PL | NCE | LC/MS/MS | 0.05 | 20 | Validated | |
VIN-NCE-83PL | NCE | LC/MS/MS | 0.05 | 20 | Validated | |
VIN-NCE-84PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-85PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-86PL | NCE | LC/MS/MS | 10 10 |
10000 2000 |
Validated | |
VIN-NCE-87PL | NCE | LC/MS/MS | 2 | 500 | Validated | |
VIN-NCE-88UR | NCE | LC/MS/MS | 1 | 100 | Validated | |
VIN-NCE-89PL | NCE | LC/MS/MS | 2.5 | 500 | Validated | |
VIN-NCE-90PL | NCE | LC/MS/MS | 1 | 6000 | Validated | |
VIN-NCE-91PL | NCE | LC/MS/MS | 1 | 5000 | Validated | |
VIN-NCE-92PL | NCE | LC/MS/MS | 0.002 | 2 | Validated | |
VIN-NCE-93PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-94UR | NCE | LC/MS/MS | 1 | 6000 | Validated | |
VIN-NCE-95UR | NCE | LC/MS/MS | 10 | 1500 | Validated | |
VIN-NCE-96PL | NCE | LC/MS/MS | 0.1 | 500 | Validated | |
VIN-NCE-97PL | NCE | LC/MS/MS | 100 | 20000 | Validated | |
VIN-NCE-98PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-99PL | NCE | LC/MS/MS | 2 | 2500 | Validated | |
VIN-NCE-100PL | NCE | LC/MS/MS | 1 | 2000 | Validated | |
VIN-NCE-101UR | NCE | LC/MS/MS | 2 | 2500 | Validated | |
VIN-NCE-102PL | NCE | LC/MS/MS | 1 | 5000 | Validated | |
VIN-NCE-103PL | NCE | LC/MS/MS | 0.2 | 1000 | Validated | |
VIN-NCE-104PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
VIN-NCE-105PL | NCE | LC/MS/MS | 0.03 | 30 | Validated | |
VIN-NCE-106PL | NCE | LC/MS/MS | 100 | 5000 | Validated | |
VIN-NCE-107UR | NCE | LC/MS/MS | 0.2 | 1000 | Validated | |
VIN-NCE-108PL | NCE | LC/MS/MS | 0.1 | 100 | Validated | |
VIN-NCE-109PL | NCE | LC/MS/MS | 1 | 5000 | Validated | |
VIN-NCE-110BL | NCE | LC/MS/MS | 0.3 | 200 | Validated | |
VIN-NCE-111PL | NCE | LC/MS/MS | 10 | 10000 | Validated | |
VIN-NCE-112SR | NCE | LC/MS/MS | 2000 | 500000 | Validated | |
VIN-NCE-113PL | NCE | LC/MS/MS | 1 | 500 | Validated | |
VIN-NCE-114PL | NCE | LC/MS/MS | 0.500 10 |
6000 10,000 |
Validated | |
VIN-NCE-115PL | NCE | LC/MS/MS | 1 | 1000 | Validated | |
20 Amino Acid (UR) | Amino acids | Generic | LC/MS/MS | 38 | 60000 | Under Validation |
Amlodipine+ Valsartan | Antihypertensive | Generic | LC/MS/MS | 0.025 20.0 |
15.0 12000 |
Under Validation |
Beclomethasone dipropionate and beclomethasone 17 monopropionate | Corticosteroids | Generic | LC/MS/MS | 10.000 10.000 |
5000 5000 |
Under Validation |
Betamethazone phosphte | corticosteroids | Generic | LC/MS/MS | 1 | 260 | Under Validation |
Buspirone | Anxiolytic | Generic | LC/MS/MS | 0.5 | 500 | Under Validation |
Carbidopa and Levodopa | Parkinson's disease | Generic | LC/MS/MS | 1.00 20.00 |
600 6000 |
Under Validation |
Carbidopa | Parkinson's disease | Generic | LC/MS/MS | 2 | 2500 | Under Validation |
Cariprazine | Antipsychotic | Generic | LC/MS/MS | 0.1 | 50 | Under Validation |
Cariprazine | Antipsychotic | Generic | LC/MS/MS | 0.01 | 10 | Under Validation |
Ciclesonide and Des-ciclesonide | Corticosteroids | Generic | LC/MS/MS | 0.050 0.005 |
10.0 1.00 |
Under Validation |
Citalopram | antidepressants | Generic | LC/MS/MS | 0.5 | 150 | Under Validation |
Clozapine | Antipsychotic | Generic | LC/MS/MS | 0.4 | 100 | Under Validation |
Dasatinib | Anticancer | Generic | LC/MS/MS | 1.5 | 525 | Under Validation |
Desmethyl Mebeverine Alcohol,Mebeverine Acid & Desmethyl Mebeverine Acid | Antispasmodic | Generic | LC/MS/MS | 0.05 1.00 4.00 |
10.0 400 1600 |
Under Validation |
Dimenhydrinate | Antihistamine | Generic | LC/MS/MS | 0.5 | 200 | Under Validation |
Enzalutamide | Metastatic castration-resistant prostate cancer (CRPC) | Generic | LC/MS/MS | 5 | 2000 | Under Validation |
Epinephrine | Alpha- and beta-adrenergic agonists | Generic | LC/MS/MS | 0.01 | 5 | Under Validation |
Favipiravir | Antiviral | Generic | LC/MS/MS | 50 | 20000 | Under Validation |
Fluvoxamine | Antidepressant | Generic | LC/MS/MS | 0.4 | 400 | Under Validation |
Indapamide | Antihypertensive | Generic | LC/MS/MS | 1 | 500 | Under Validation |
Itraconazole and metabolite | Antifungal | Generic | LC/MS/MS | 0.500 0.625 |
400 500 |
Under Validation |
Lapatinib | Anticancer | Generic | LC/MS/MS | 10 | 8000 | Under Validation |
Metoprolol and Hydrochlorothaizide | Antihypertensive | Generic | LC/MS/MS | 1 | 500 | Under Validation |
Desmethyl mebeverine alcohol , Mebeverine Acid & Desmethyl Mebeverine Acid | Antispasmodic | Generic | LC/MS/MS | 0.050 1.00 4.00 |
10.0 400 1600 |
Under Validation |
Mirabegron | Urinary incontinence | Generic | LC/MS/MS | 0.1 | 80 | Under Validation |
N-Acetyl -L-Cysteine (UR) | Amino acids | Generic | LC/MS/MS | 20 | 4000 | Under Validation |
Norethisterone (Norethindrone) | Progestogen | Generic | LC/MS/MS | 0.05 | 20 | Under Validation |
Norketotifen | Asthma medication | Generic | LC/MS/MS | 0.1 | 25 | Under Validation |
Occidiofungin | Antifungal | Generic | LC/MS/MS | 1 | 500 | Under Validation |
Pantoprazole | Proton pump inhibitor | Generic | LC/MS/MS | 10 | 8000 | Under Validation |
Phenyl butyrate | Aromatic fatty acid | Generic | LC/MS/MS | 800 | 400000 | Under Validation |
Phenoxymethylpenicillin | β-lactam antibiotics | Generic | LC/MS/MS | 10 | 6000 | Under Validation |
Pyridoxal | Vitamin B6 | Generic | LC/MS/MS | 0.5 | 200 | Under Validation |
Cis & Trans-Phytonadione | Vitamin K | Generic | LC/MS/MS | 0.1 0.2 |
200 400 |
Under Validation |
Prazosin | Alpha-blockers | Generic | LC/MS/MS | 1 | 400 | Under Validation |
Progesterone | Progestogen | Generic | LC/MS/MS | 0.1 | 100 | Under Validation |
Quetiapine | Antipsychotic | Generic | LC/MS/MS | 1 | 300 | Under Validation |
Saxagliptin + 5-Hydroxy Saxagliptin | Antidiabetic | Generic | LC/MS/MS | 0.20 0.40 |
100 200 |
Under Validation |
Taurursodiol | Gallstone dissolution agents | Generic | LC/MS/MS | 20 | 3000 | Under Validation |
Tezacaftor and Ivacaftor | CFTR | Generic | LC/MS/MS | 30.00 7.500 |
12000 3000 |
Under Validation |
Verapamil + Norverapamil | Antihypertensive | Generic | LC/MS/MS | 0.50 0.50 |
250 250 |
Under Validation |
Ventoclax | Chronic lymphocytic leukemia | Generic | LC/MS/MS | 0.1 | 200 | Under Validation |
Veratric Acid | Anti-cancer | Generic | LC/MS/MS | 60 | 12000 | Under Validation |
Vigabatrin | Antiepileptic | Generic | LC/MS/MS | 500 | 300000 | Under Validation |
Zileuton | Asthma | Generic | LC/MS/MS | 20 | 10000 | Under Validation |
Nitrate | PD Biomarker | Colourimetric | 5 µM | 35 µM | Validated | |
Nitrite | PD Biomarker | Colourimetric | 5 µM | 35 µM | Validated | |
Anti Xa | PD Biomarker | Chromogenic | 0.1 IU/mL | 1 IU/mL | Validated | |
Anti IIa | PD Biomarker | Chromogenic | 0.05 IU/mL | 0.2 IU/mL | Validated | |
TFPI | PD Biomarker | ELISA- Colorimetric | 31.25 pg/mL | 2 ng/mL | Validated | |
C-Peptide | PD Biomarker | ELISA | 28.89 pM | 1850 pM | Validated | |
C-Peptide (Human) | PD Biomarker | ECLIA | 40 pmol/L | 4000 pmol/L | Validated | |
Heparin Clotting Assay | PD Biomarker | Clotting Assay | 0.15 IU/mL | 1 IU/mL | Validated | |
IgG | Immunogenicity | Qualitative-ELISA Method | Validated | |||
IgA | Immunogenicity | Qualitative-ELISA Method | Validated | |||
IgM | Immunogenicity | Qualitative-ELISA Method | Validated | |||
IgGAM | Immunogenicity | Qualitative-ELISA Method | Validated | |||
Insulin Human | Antidiabetic | Biotherapeutics | ECLIA | 10 pmol/L | 2500 pmol/L | Validated |
Insulin Aspart | Antidiabetic | Biotherapeutics | ELISA | 15.714 pM | 500 pM | Validated |
Insulin Aspart | Antidiabetic | Biotherapeutics | LC/MS/MS | 0.1 | 5 | Validated |
A-H-PF4 | Immunogenicity | ELISA- Colorimetric | Validated | |||
Total Iron | Iron Defficiency Anaemia | PD Biomarker | Colourimetric | 500 ng/mL | 60000 ng/mL | Validated |
Teriperatide (PTH) | Osteoporosis | Biotherapeutics | ELISA | 0.015 | 0.2 | |
Transferrin bound Iron(TBI) | Iron Defficiency Anaemia | PD Biomarker | Colorimetric | 200 ng/mL | 8000 ng/mL | Validated |
Anti Xa | PD Biomarker | Chromogenic | 0.1 IU/mL | 1 IU/mL | Validated | |
Anti IIa | PD Biomarker | Chromogenic | 0.05 IU/mL | 0.2 IU/mL | Validated | |
TFPI | PD Biomarker | ELISA | 31.25 pg/mL | 2 ng/mL | Validated | |
C-Peptide | PD Biomarker | ELISA | 28.89 pM | 1850 pM | Validated | |
G-CSF | Neutropenia | Biotherapeutics | ELISA | 2.014 ng/mL | 50 ng/mL | Validated |
Insulin Aspart | Anti Diabetic | Biotherapeutics | ELISA | 15.714 pM | 500 pM | Validated |
Teriperatide-PK (PTH) | Oestioporosis | Biotherapeutics | ELISA | 15 pg/mL | 200 pg/mL | Validated |
Anti SARS CoV-2 IgG titer | Immunogenicity | ELISA | 5 ng/mL | 1500 ng/mL | Validated | |
r-hFSH | Infertility Therapy | Biotherapeutics | ELISA | 0.5 mIU/mL | 20 mIU/mL | Validated |
Total Antioxidant capacity of Serum (TAC) | PD Biomarker | Chromogenic | 3.906 µM | 1000 µM | Validated | |
Teriparatide ADA | Immunogenicity | ELISA | Validated | |||
Tocilizumab ADA | Immunogenicity | ELISA | Under Validation | |||
Tocilizumab PK | Anti-arthritic drug/Covid-19 | Biotherapeutics | ELISA | 0.415 µg/mL | 12.5 µg/mL | Under Validation |
Soluble IL-6R alpha | PD Biomarker | ELISA | 31.3 pg/mL | 2000 pg/mL | Under Validation | |
Tocilizumab Nab | Immunogenicity | ELISA | Under Validation |